including CUI

9fc2351e · Silvio Domingos CARDOSO · 48fb794f · 9fc2351e · 9fc2351e · 9fc2351e
Commit 9fc2351e authored Nov 02, 2018 by Silvio Domingos CARDOSO
12 changed files
--- a/Direct Maintenance/DataSet_2010/ncit_evolved_in_2010.csv
+++ b/Direct Maintenance/DataSet_2010/ncit_evolved_in_2010.csv
-document;concept;annotation;start;end;kosAtt
+document,concept,annotation,start,end,kosAtt
-2630847.nxml;C822;salt;31078;31082;Salt
+2630847.nxml,C0036140,salt,31078,31082,Salt
-2630848.nxml;C51980;product;5675;5682;Product
+2630848.nxml,C1514468,product,5675,5682,Product
-2630943.nxml;C64495;chloride;5565;5573;chloride
+2630943.nxml,C0201952,chloride,5565,5573,chloride
-2630944.nxml;C70713;Type of sample;25439;25453;Sample Type
+2630944.nxml,C2347029,Type of sample,25439,25453,Sample Type
-2630947.nxml;C64941;External Use;6663;6675;External Use
+2630947.nxml,C0521134,External Use,6663,6675,External Use
-2630960.nxml;C17041;public policy;34912;34925;Public Policy
+2630960.nxml,C0034033,public policy,34912,34925,Public Policy
-2630962.nxml;C12742;lower extremities;5309;5326;Lower Extremity
+2630962.nxml,C0023216,lower extremities,5309,5326,Lower Extremity
-2630977.nxml;C35136;Peripheral Vascular Disease;21627;21654;Peripheral Vascular Disease
+2630977.nxml,C0085096,Peripheral Vascular Disease,21627,21654,Peripheral Vascular Disease
-2630978.nxml;C27221;nerve entrapment;17195;17211;Entrapment Neuropathy
+2630978.nxml,C1510429,nerve entrapment,17195,17211,Entrapment Neuropathy
-2630994.nxml;C75608;ikk gamma;10171;10180;NEMO
+2630994.nxml,C2697645,ikk gamma,10171,10180,NEMO
-2631011.nxml;C18456;labeling index;18554;18568;Labeling Index
+2631011.nxml,C0812425,labeling index,18554,18568,Labeling Index
-2631011.nxml;C18456;labeling index;18554;18568;Labeling Index
+2631011.nxml,C0812425,labeling index,18554,18568,Labeling Index
-2631502.nxml;C1145;lignan;60674;60680;Lignan
+2631502.nxml,C0064971,lignan,60674,60680,Lignan
-2633361.nxml;C50427;Retrograde Flow;1895;1910;Retrograde Flow
+2633361.nxml,C1709934,Retrograde Flow,1895,1910,Retrograde Flow
-2634620.nxml;C65294;Cefepime;6266;6274;Cefepime
+2634620.nxml,C0055003,Cefepime,6266,6274,Cefepime
-2634707.nxml;C63590;folfox-4;18556;18564;FOLFOX-4 Regimen
+2634707.nxml,C1880659,folfox-4,18556,18564,FOLFOX-4 Regimen
-2634727.nxml;C20586;hematopoietic colony-stimulating factors;21443;21483;Colony-Stimulating Factors
+2634727.nxml,C0009392,hematopoietic colony-stimulating factors,21443,21483,Colony-Stimulating Factors
-2635365.nxml;C2278;Inhibin Beta e;26324;26338;Inhibin Beta
+2635365.nxml,C0971174,Inhibin Beta e,26324,26338,Inhibin Beta
-2635601.nxml;C1685;trail Apo2L;17765;17776;APO2L/TRAIL
+2635601.nxml,C1522480,trail Apo2L,17765,17776,APO2L/TRAIL
-2635603.nxml;C79876;microcrystalline Cellulose powders;24206;24240;Cellulose, Microcrystalline
+2635603.nxml,C0669247,microcrystalline Cellulose powders,24206,24240,"Cellulose, Microcrystalline"
-2635670.nxml;C20533;TNF-related apoptosis-inducing ligand;6646;6683;TNF-Related Apoptosis Inducing Ligand TRAIL
+2635670.nxml,C0385242,TNF-related apoptosis-inducing ligand,6646,6683,TNF-Related Apoptosis Inducing Ligand TRAIL
-2636027.nxml;C14316;Infective Agents;6474;6490;Infective Agent
+2636027.nxml,C0314732,Infective Agents,6474,6490,Infective Agent
-2636142.nxml;C66877;Indinavir;49821;49830;Indinavir
+2636142.nxml,C0376637,Indinavir,49821,49830,Indinavir
-2636761.nxml;C71252;blood gas analysis;9093;9111;Blood Gas Analysis
+2636761.nxml,C0150411,blood gas analysis,9093,9111,Blood Gas Analysis
-2636825.nxml;C1397;protein e6;14844;14854;Protein E6
+2636825.nxml,C0133938,protein e6,14844,14854,Protein E6
-2637848.nxml;C14421;inbred mouse strain;36467;36486;Inbred Mouse Strains
+2637848.nxml,C0025927,inbred mouse strain,36467,36486,Inbred Mouse Strains
-2638874.nxml;C20545;granulocyte macrophage colony-stimulating factor;12191;12239;Granulocyte Macrophage Colony-Stimulating Factor
+2638874.nxml,C0079460,granulocyte macrophage colony-stimulating factor,12191,12239,Granulocyte Macrophage Colony-Stimulating Factor
-2639026.nxml;C63662;beta-sitosterol;22334;22349;Beta-sitosterol
+2639026.nxml,C0106127,beta-sitosterol,22334,22349,Beta-sitosterol
-2639207.nxml;C20545;granulocyte-macrophage colony stimulating factor;55173;55221;granulocyte-macrophage colony stimulating factor
+2639207.nxml,C0079460,granulocyte-macrophage colony stimulating factor,55173,55221,granulocyte-macrophage colony stimulating factor
-2639550.nxml;C71632;Meperidine;11813;11823;Meperidine
+2639550.nxml,C0025376,Meperidine,11813,11823,Meperidine
-2639605.nxml;C74563;fitzpatrick's classification of skin type;8362;8403;Fitzpatrick Classification Scale
+2639605.nxml,C2700191,fitzpatrick's classification of skin type,8362,8403,Fitzpatrick Classification Scale
-2642848.nxml;C21104;the source of pain;4929;4947;Pain Origin
+2642848.nxml,C1518853,the source of pain,4929,4947,Pain Origin
-2643481.nxml;C29681;GTF3C1;17253;17259;GTF3C1
+2643481.nxml,C0145477,GTF3C1,17253,17259,GTF3C1
-2644663.nxml;C67388;Liters per Minute;38477;38494;Liters per Minute
+2644663.nxml,C0439393,Liters per Minute,38477,38494,Liters per Minute
-2646651.nxml;C19177;speech pathologist;13404;13422;speech pathologist
+2646651.nxml,C0402015,speech pathologist,13404,13422,speech pathologist
-2648799.nxml;C47824;data set;1446;1454;Dataset
+2648799.nxml,C0150098,data set,1446,1454,Dataset
-2649160.nxml;C75498;Glycerol Kinase Gene;36596;36616;Glycerol Kinase Gene
+2649160.nxml,C1415082,Glycerol Kinase Gene,36596,36616,Glycerol Kinase Gene
-2649160.nxml;C75498;Glycerol Kinase Gene;36596;36616;Glycerol Kinase Gene
+2649160.nxml,C1415082,Glycerol Kinase Gene,36596,36616,Glycerol Kinase Gene
-2630914.nxml;C48570;percent;21653;21660;percent
+2630914.nxml,C0439165,percent,21653,21660,percent
-2630997.nxml;C16508;DNA methyltransferases;4574;4596;DNA Methyltransferase
+2630997.nxml,C0012873,DNA methyltransferases,4574,4596,DNA Methyltransferase
-2631224.nxml;C73691;Dnmt3a;66061;66067;Dnmt3a
+2631224.nxml,C2348048,Dnmt3a,66061,66067,Dnmt3a
-2631225.nxml;C62069;piperacillin;21547;21559;Piperacillin
+2631225.nxml,C0031955,piperacillin,21547,21559,Piperacillin
-2631502.nxml;C1145;lignans;59899;59906;lignan
+2631502.nxml,C0064971,lignans,59899,59906,lignan
-2631593.nxml;C44175;input value;26505;26516;Parameter Value
+2631593.nxml,C0549193,input value,26505,26516,Parameter Value
-2633164.nxml;C64798;MCHC;9622;9626;Erythrocyte Mean Corpuscular Hemoglobin Concentration
+2633164.nxml,C0474535,MCHC,9622,9626,Erythrocyte Mean Corpuscular Hemoglobin Concentration
-2634758.nxml;C497;fish oils;30069;30078;fish oil
+2634758.nxml,C0016157,fish oils,30069,30078,fish oil
-2636806.nxml;C50414;required hospitalization;28291;28315;Hospitalization required
+2636806.nxml,C1708385,required hospitalization,28291,28315,Hospitalization required
-2644589.nxml;C25473;every day;15878;15887;Daily
+2644589.nxml,C0332173,every day,15878,15887,Daily
-2644690.nxml;C21490;ubiquitin carboxy-terminal hydrolase;62081;62117;Ubiquitin Carboxyl-Terminal Hydrolase BAP1
+2644690.nxml,C1368335,ubiquitin carboxy-terminal hydrolase,62081,62117,Ubiquitin Carboxyl-Terminal Hydrolase BAP1
-2647295.nxml;C2407;MUC1 mucin;19058;19068;MUC-1 Antigen
+2647295.nxml,C0006611,MUC1 mucin,19058,19068,MUC-1 Antigen
-2647780.nxml;C69128;R788;65529;65533;r788 sodium
+2647780.nxml,C2713022,R788,65529,65533,r788 sodium
-2648039.nxml;C49291;principle component analysis;27898;27926;Principal Component Analysis
+2648039.nxml,C0429865,principle component analysis,27898,27926,Principal Component Analysis
-2631072.nxml;C62071;primaquine;21778;21788;primaquine
+2631072.nxml,C0033126,primaquine,21778,21788,primaquine
-2630847.nxml;C29974;salt;31078;31086;Salt
+2630847.nxml,C0037494,salt,31078,31086,Salt
-2630848.nxml;C40352;product;5675;5689;Product
+2630848.nxml,C1704444,product,5675,5689,Product
-2630943.nxml;C1741;chloride;5565;5581;chloride
+2630943.nxml,C0596019,chloride,5565,5581,chloride
-2643481.nxml;C20665;GTF3C1;17253;17265;GTF3C1
+2643481.nxml,C1333724,GTF3C1,17253,17265,GTF3C1
-2649160.nxml;C75499;Glycerol Kinase Gene;36596;36616;Glycerol Kinase Gene
+2649160.nxml,C2700225,Glycerol Kinase Gene,36596,36616,Glycerol Kinase Gene
-2649160.nxml;C75499;Glycerol Kinase Gene;36596;36616;Glycerol Kinase Gene
+2649160.nxml,C2700225,Glycerol Kinase Gene,36596,36616,Glycerol Kinase Gene
-2630914.nxml;C25613;percent;21653;21660;percent
+2630914.nxml,C0439165,percent,21653,21660,percent
-2631224.nxml;C73652;Dnmt3a;66061;66067;Dnmt3a
+2631224.nxml,C1414123,Dnmt3a,66061,66067,Dnmt3a
--- a/Direct Maintenance/DataSet_2010/ncit_impacted_in_2010.csv
+++ b/Direct Maintenance/DataSet_2010/ncit_impacted_in_2010.csv
-document;concept;annotation;start;end
+document,concept,annotation,start,end
-2630847.nxml;C72068;Salt;31078;31082
+2630847.nxml,C0206136,Salt,31078,31082
-2630848.nxml;C71610;product;5675;5682
+2630848.nxml,C2347741,product,5675,5682
-2630943.nxml;C68244;chloride;5565;5573
+2630943.nxml,C0008203,chloride,5565,5573
-2630944.nxml;C53193;Type of sample;25439;25453
+2630944.nxml,C0449370,Type of sample,25439,25453
-2630947.nxml;C65038;external use;6663;6675
+2630947.nxml,C1882285,external use,6663,6675
-2630960.nxml;C17735;public policy;34912;34925
+2630960.nxml,C0034033,public policy,34912,34925
-2630962.nxml;C30140;extremities;5315;5326
+2630962.nxml,C0015385,extremities,5315,5326
-2630977.nxml;C50694;peripheral vascular disease;21627;21654
+2630977.nxml,C0085096,peripheral vascular disease,21627,21654
-2630978.nxml;C50548;entrapment;17201;17211
+2630978.nxml,C1962925,entrapment,17201,17211
-2630994.nxml;C68914;gamma;10175;10180
+2630994.nxml,C2349976,gamma,10175,10180
-2631011.nxml;C54694;labeling;18554;18562
+2631011.nxml,C1947902,labeling,18554,18562
-2631011.nxml;C25390;index;18563;18568
+2631011.nxml,C0918012,index,18563,18568
-2631502.nxml;C68494;lignan;60674;60680
+2631502.nxml,C2346673,lignan,60674,60680
-2633361.nxml;C73500;retrograde flow;1895;1910
+2633361.nxml,C2347959,retrograde flow,1895,1910
-2634620.nxml;C1041;cefepime;6266;6274
+2634620.nxml,C0771284,cefepime,6266,6274
-2634707.nxml;C11197;FOLFOX;18556;18562
+2634707.nxml,C0392943,FOLFOX,18556,18562
-2634727.nxml;C1288;hematopoietic colony-stimulating factors;21443;21483
+2634727.nxml,C0376563,hematopoietic colony-stimulating factors,21443,21483
-2635365.nxml;C1349;Inhibin beta;26324;26336
+2635365.nxml,C1527008,Inhibin beta,26324,26336
-2635601.nxml;C1685;Apo2L;17771;17776
+2635601.nxml,C1522480,Apo2L,17771,17776
-2635603.nxml;C68491;Cellulose;24223;24232
+2635603.nxml,C0007648,Cellulose,24223,24232
-2635670.nxml;C1685;TNF-related apoptosis-inducing ligand;6646;6683
+2635670.nxml,C1522480,TNF-related apoptosis-inducing ligand,6646,6683
-2636027.nxml;C50922;infective agents;6474;6490
+2636027.nxml,C0450254,infective agents,6474,6490
-2636142.nxml;C1662;indinavir;49821;49830
+2636142.nxml,C0700483,indinavir,49821,49830
-2636761.nxml;C12434;blood;9093;9098
+2636761.nxml,C0229664,blood,9093,9098
-2636825.nxml;C41172;protein;14844;14851
+2636825.nxml,C1521746,protein,14844,14851
-2637848.nxml;C14421;inbred mouse;36467;36479
+2637848.nxml,C1512690,inbred mouse,36467,36479
-2638874.nxml;C1288;granulocyte macrophage colony-stimulating factor;12191;12239
+2638874.nxml,C0376563,granulocyte macrophage colony-stimulating factor,12191,12239
-2639026.nxml;C68324;beta-sitosterol;22334;22349
+2639026.nxml,C0106127,beta-sitosterol,22334,22349
-2639207.nxml;C1288;granulocyte-macrophage colony stimulating factor;55173;55221
+2639207.nxml,C0376563,granulocyte-macrophage colony stimulating factor,55173,55221
-2639550.nxml;C635;meperidine;11813;11823
+2639550.nxml,C0353148,meperidine,11813,11823
-2639605.nxml;C25284;type;8399;8403
+2639605.nxml,C0332307,type,8399,8403
-2642848.nxml;C53837;pain;4943;4947
+2642848.nxml,C1882272,pain,4943,4947
-2643481.nxml;C52627;GTF3c1;17253;17259
+2643481.nxml,C1705412,GTF3c1,17253,17259
-2644663.nxml;C69160;liters per minute;38477;38494
+2644663.nxml,C2346686,liters per minute,38477,38494
-2646651.nxml;C28247;speech pathologist;13404;13422
+2646651.nxml,C0402015,speech pathologist,13404,13422
-2648799.nxml;C25474;data;1446;1450
+2648799.nxml,C1511726,data,1446,1450
-2649160.nxml;C28597;kinase;36605;36611
+2649160.nxml,C0031727,kinase,36605,36611
-2649160.nxml;C29077;glycerol;36596;36604
+2649160.nxml,C0017861,glycerol,36596,36604
-2630914.nxml;C25613;percent;21653;21660
+2630914.nxml,C0439165,percent,21653,21660
-2630997.nxml;C16508;DNA methyltransferases;4574;4596
+2630997.nxml,C0012873,DNA methyltransferases,4574,4596
-2631224.nxml;C73653;Dnmt3a;66061;66067
+2631224.nxml,C2348050,Dnmt3a,66061,66067
-2631225.nxml;C749;piperacillin;21547;21559
+2631225.nxml,C0031955,piperacillin,21547,21559
-2631502.nxml;C1145;lignans;59899;59906
+2631502.nxml,C0064971,lignans,59899,59906
-2631593.nxml;C44175;input value;26505;26516
+2631593.nxml,C0549193,input value,26505,26516
-2633164.nxml;C64798;MCHC;9622;9626
+2633164.nxml,C0474535,MCHC,9622,9626
-2634758.nxml;C497;fish oils;30069;30078
+2634758.nxml,C0016157,fish oils,30069,30078
-2636806.nxml;C50414;required hospitalization;28291;28315
+2636806.nxml,C1708385,required hospitalization,28291,28315
-2644589.nxml;C25473;every day;15878;15887
+2644589.nxml,C0332173,every day,15878,15887
-2644690.nxml;C21490;ubiquitin carboxy-terminal hydrolase;62081;62117
+2644690.nxml,C1368335,ubiquitin carboxy-terminal hydrolase,62081,62117
-2647295.nxml;C2407;MUC1 mucin;19058;19068
+2647295.nxml,C0006611,MUC1 mucin,19058,19068
-2647780.nxml;C69128;R788;65529;65533
+2647780.nxml,C2348126,R788,65529,65533
-2648039.nxml;C49291;principle component analysis;27898;27926
+2648039.nxml,C0429865,principle component analysis,27898,27926
-2631072.nxml;C771;primaquine;21778;21788
+2631072.nxml,C0033126,primaquine,21778,21788
--- a/Direct Maintenance/DataSet_2010/ncit_original_annot_in_2009.csv
+++ b/Direct Maintenance/DataSet_2010/ncit_original_annot_in_2009.csv
-kos;document;class;sentence;startOffset;endOffset;prefix;sufix
+kos,document,class,sentence,startOffset,endOffset,prefix,sufix
-NCIT2009;2630847.nxml;C72068;Salt;31078;31082; p new nectriapyrones by; water culture of a fungus
+NCIT2009,2630847.nxml,C0206136,Salt,31078,31082, p new nectriapyrones by, water culture of a fungus
-NCIT2009;2630848.nxml;C71610;product;5675;5682; yielded 3 as the main;. compound 3 possesses a
+NCIT2009,2630848.nxml,C2347741,product,5675,5682, yielded 3 as the main,. compound 3 possesses a
-NCIT2009;2630914.nxml;C25613;percent;21653;21660; transcript abundances. twenty-two; of the genes in cluster
+NCIT2009,2630914.nxml,C0439165,percent,21653,21660, transcript abundances. twenty-two, of the genes in cluster
-NCIT2009;2630943.nxml;C68244;chloride;5565;5573; encodes an anion ;/iodide) transporter
+NCIT2009,2630943.nxml,C0008203,chloride,5565,5573, encodes an anion ,/iodide) transporter
-NCIT2009;2630944.nxml;C53193;Type of sample;25439;25453; by reducing variance. iv.; dna, rna and protein
+NCIT2009,2630944.nxml,C0449370,Type of sample,25439,25453, by reducing variance. iv.," dna, rna and protein"
-NCIT2009;2630947.nxml;C65038;external use;6663;6675; used as oral administration or;. in treating conjunctivitis
+NCIT2009,2630947.nxml,C1882285,external use,6663,6675, used as oral administration or,. in treating conjunctivitis
-NCIT2009;2630960.nxml;C17735;public policy;34912;34925; survey data to inform;: comparison of
+NCIT2009,2630960.nxml,C0034033,public policy,34912,34925, survey data to inform,: comparison of
-NCIT2009;2630962.nxml;C30140;extremities;5315;5326; assessment of the lower;. body constitution is
+NCIT2009,2630962.nxml,C0015385,extremities,5315,5326, assessment of the lower,. body constitution is
-NCIT2009;2630977.nxml;C50694;peripheral vascular disease;21627;21654; pressure, heart disease,;, diabetes, focal
+NCIT2009,2630977.nxml,C0085096,peripheral vascular disease,21627,21654," pressure, heart disease,",", diabetes, focal"
-NCIT2009;2630978.nxml;C50548;entrapment;17201;17211; after sciatic nerve; (sne) sne is a variation
+NCIT2009,2630978.nxml,C1962925,entrapment,17201,17211, after sciatic nerve, (sne) sne is a variation
-NCIT2009;2630994.nxml;C68914;gamma;10175;10180; to mutations in ikk; (nemo) am j hum genet 2000
+NCIT2009,2630994.nxml,C2349976,gamma,10175,10180, to mutations in ikk, (nemo) am j hum genet 2000
-NCIT2009;2630997.nxml;C16508;DNA methyltransferases;4574;4596; together with; (mtases) of the same or
+NCIT2009,2630997.nxml,C0012873,DNA methyltransferases,4574,4596, together with, (mtases) of the same or
-NCIT2009;2631011.nxml;C54694;labeling;18554;18562; tumors above the median; index were categorized as
+NCIT2009,2631011.nxml,C1947902,labeling,18554,18562, tumors above the median, index were categorized as
-NCIT2009;2631011.nxml;C25390;index;18563;18568; above the median labeling;" were categorized as high ki-67;"
+NCIT2009,2631011.nxml,C0918012,index,18563,18568, above the median labeling, were categorized as high ki-67;
-NCIT2009;2631072.nxml;C771;primaquine;21778;21788; treating the cell with; (pmq), a receptor recycling
+NCIT2009,2631072.nxml,C0033126,primaquine,21778,21788, treating the cell with," (pmq), a receptor recycling"
-NCIT2009;2631131.nxml;C16428;China;938;943; of;, beijing,
+NCIT2009,2631131.nxml,C0008115,China,938,943, of,", beijing,"
-NCIT2009;2631224.nxml;C73653;Dnmt3a;66061;66067; n kasai m kouzarides t; binds deacetylases and is
+NCIT2009,2631224.nxml,C2348050,Dnmt3a,66061,66067, n kasai m kouzarides t, binds deacetylases and is
-NCIT2009;2631225.nxml;C749;piperacillin;21547;21559; with cefepim, meropenem,; and gentamicin against
+NCIT2009,2631225.nxml,C0031955,piperacillin,21547,21559," with cefepim, meropenem,", and gentamicin against
-NCIT2009;2631502.nxml;C1145;lignans;59899;59906; dna sequence-selective plant; proc natl acad sci usa
+NCIT2009,2631502.nxml,C0064971,lignans,59899,59906, dna sequence-selective plant, proc natl acad sci usa
-NCIT2009;2631502.nxml;C68494;lignan;60674;60680; nordihydroguaiaretic acid plant; derivatives antiviral research 2000
+NCIT2009,2631502.nxml,C2346673,lignan,60674,60680, nordihydroguaiaretic acid plant, derivatives antiviral research 2000
-NCIT2009;2631587.nxml;C16612;genes;55606;55611; the induction of p53 target; by sxr activators in cells
+NCIT2009,2631587.nxml,C0017337,genes,55606,55611, the induction of p53 target, by sxr activators in cells
-NCIT2009;2631593.nxml;C44175;input value;26505;26516; false discovery rate (fdr); (herein set to 0.01) or
+NCIT2009,2631593.nxml,C0549193,input value,26505,26516, false discovery rate (fdr), (herein set to 0.01) or
-NCIT2009;2632676.nxml;C12602;Sperm;38681;38686; 307 313 10714886 parker g; competition and its
+NCIT2009,2632676.nxml,C0037868,Sperm,38681,38686, 307 313 10714886 parker g, competition and its
-NCIT2009;2632756.nxml;C16351;Biotechnology;988;1001; of life sciences and;, shanghai jiao
+NCIT2009,2632756.nxml,C0005574,Biotechnology,988,1001, of life sciences and,", shanghai jiao"
-NCIT2009;2633046.nxml;C45281;object;2705;2711; with the ucs. pre-exposure to; distress increased the freezing
+NCIT2009,2633046.nxml,C0347997,object,2705,2711, with the ucs. pre-exposure to, distress increased the freezing
-NCIT2009;2633164.nxml;C64798;MCHC;9622;9626; (p<.05). the mcv, mch,; and ferritin levels were
+NCIT2009,2633164.nxml,C0474535,MCHC,9622,9626," (p<.05). the mcv, mch,", and ferritin levels were
-NCIT2009;2633361.nxml;C73500;retrograde flow;1895;1910; double syndrome as; in the right vertebral artery
+NCIT2009,2633361.nxml,C2347959,retrograde flow,1895,1910, double syndrome as, in the right vertebral artery
-NCIT2009;2634620.nxml;C1041;cefepime;6266;6274; cephalosporins,;, imipenem,
+NCIT2009,2634620.nxml,C0771284,cefepime,6266,6274," cephalosporins,",", imipenem,"
-NCIT2009;2634691.nxml;C16311;Australia;11814;11823; (invitrogen corporation, melbourne,;) in the presence of
+NCIT2009,2634691.nxml,C0004340,Australia,11814,11823," (invitrogen corporation, melbourne,",) in the presence of
-NCIT2009;2634703.nxml;C15313;irradiation;43767;43778; cell lines. combination of; and 17-aag induced a higher
+NCIT2009,2634703.nxml,C1522449,irradiation,43767,43778, cell lines. combination of, and 17-aag induced a higher
-NCIT2009;2634707.nxml;C11197;FOLFOX;18556;18562; addition of cetuximab to;-4 had a detrimental
+NCIT2009,2634707.nxml,C0392943,FOLFOX,18556,18562, addition of cetuximab to,-4 had a detrimental
-NCIT2009;2634727.nxml;C1288;hematopoietic colony-stimulating factors;21443;21483; for the use of;: evidence-based, clinical
+NCIT2009,2634727.nxml,C0376563,hematopoietic colony-stimulating factors,21443,21483, for the use of,": evidence-based, clinical"
-NCIT2009;2634758.nxml;C497;fish oils;30069;30078; of arrhythmias by n-3; circulation 2003 107 2646
+NCIT2009,2634758.nxml,C0016157,fish oils,30069,30078, of arrhythmias by n-3, circulation 2003 107 2646
-NCIT2009;2634779.nxml;C18635;area;22000;22004; of bone; and bone volume values has
+NCIT2009,2634779.nxml,C1510751,area,22000,22004, of bone, and bone volume values has
-NCIT2009;2635365.nxml;C1349;Inhibin beta;26324;26336; expression was observed for; e chain (inhbe), a
+NCIT2009,2635365.nxml,C1527008,Inhibin beta,26324,26336, expression was observed for," e chain (inhbe), a"
-NCIT2009;2635601.nxml;C1685;Apo2L;17771;17776; inducing ligand (trail;) and genistein is
+NCIT2009,2635601.nxml,C1522480,Apo2L,17771,17776, inducing ligand (trail,) and genistein is
-NCIT2009;2635603.nxml;C68491;Cellulose;24223;24232; variations of microcrystalline; powders powder techn 1998 98
+NCIT2009,2635603.nxml,C0007648,Cellulose,24223,24232, variations of microcrystalline, powders powder techn 1998 98
-NCIT2009;2635670.nxml;C1685;TNF-related apoptosis-inducing ligand;6646;6683; necrosis factor (tnf) receptor,; (trail) receptor and fas
+NCIT2009,2635670.nxml,C1522480,TNF-related apoptosis-inducing ligand,6646,6683," necrosis factor (tnf) receptor,", (trail) receptor and fas
-NCIT2009;2635670.nxml;C12508;Cell;30244;30248; bcl-2 protein family exp; res 2000 256 1 50
+NCIT2009,2635670.nxml,C0007634,Cell,30244,30248, bcl-2 protein family exp, res 2000 256 1 50
-NCIT2009;2635709.nxml;C48058;energy;32230;32236; force by spending the; indicated as
+NCIT2009,2635709.nxml,C0542479,energy,32230,32236, force by spending the, indicated as
-NCIT2009;2635739.nxml;C42768;role;36761;36765; precise structural layout and; of the capillary and
+NCIT2009,2635739.nxml,C1705809,role,36761,36765, precise structural layout and, of the capillary and
-NCIT2009;2635953.nxml;C15206;study;22001;22006; women. 27 another; concluded that, while there
+NCIT2009,2635953.nxml,C0008972,study,22001,22006, women. 27 another," concluded that, while there"
-NCIT2009;2636027.nxml;C50922;infective agents;6474;6490; the most common;, the necrotic base of
+NCIT2009,2636027.nxml,C0450254,infective agents,6474,6490, the most common,", the necrotic base of"
-NCIT2009;2636142.nxml;C1662;indinavir;49821;49830; to years after starting; therapy have also been
+NCIT2009,2636142.nxml,C0700483,indinavir,49821,49830, to years after starting, therapy have also been
-NCIT2009;2636761.nxml;C12434;blood;9093;9098; results from arterial; gas analysis (ph, pao2)
+NCIT2009,2636761.nxml,C0229664,blood,9093,9098, results from arterial," gas analysis (ph, pao2)"
-NCIT2009;2636763.nxml;C459;medication;21711;21721; and mean dose of hypnotic;. patients will also keep
+NCIT2009,2636763.nxml,C0013227,medication,21711,21721, and mean dose of hypnotic,. patients will also keep
-NCIT2009;2636806.nxml;C50414;required hospitalization;28291;28315; level of sickness that; would be a deterring
+NCIT2009,2636806.nxml,C1708385,required hospitalization,28291,28315, level of sickness that, would be a deterring
-NCIT2009;2636825.nxml;C41172;protein;14844;14851; lesions. they identified; e6 and -7 in six of
+NCIT2009,2636825.nxml,C1521746,protein,14844,14851, lesions. they identified, e6 and -7 in six of
-NCIT2009;2636833.nxml;C66836;five;8701;8705; that were larger than; years in the original
+NCIT2009,2636833.nxml,C0205451,five,8701,8705, that were larger than, years in the original
-NCIT2009;2637428.nxml;C64917;affected;23813;23821; and removal of injured or; cells [reviewed in 31]
+NCIT2009,2637428.nxml,C0392760,affected,23813,23821, and removal of injured or, cells [reviewed in 31]
-NCIT2009;2637848.nxml;C14421;inbred mouse;36467;36479; this strain background. the; strain carrying the mutation
+NCIT2009,2637848.nxml,C1512690,inbred mouse,36467,36479, this strain background. the, strain carrying the mutation
-NCIT2009;2638200.nxml;C70813;voltage;37255;37262; effects of ?1 on the;#NAME?
+NCIT2009,2638200.nxml,C0598352,voltage,37255,37262, effects of ?1 on the,#NAME?
-NCIT2009;2638874.nxml;C1288;granulocyte-macrophage colony stimulating factor;12191;12239; in vitro culture in murine;" (100 ng ml ?1 ; amgen,"
+NCIT2009,2638874.nxml,C0376563,granulocyte-macrophage colony stimulating factor,12191,12239, in vitro culture in murine," (100 ng ml ?1 ; amgen,"
-NCIT2009;2639026.nxml;C68324;beta-sitosterol;22334;22349; triterpene alcohols with; the most abundant
+NCIT2009,2639026.nxml,C0106127,beta-sitosterol,22334,22349, triterpene alcohols with, the most abundant
-NCIT2009;2639035.nxml;C25300;culture;43539;43546; 17. milyavsky m prolonged; of telomerase-immortalized human
+NCIT2009,2639035.nxml,C0430400,culture,43539,43546, 17. milyavsky m prolonged, of telomerase-immortalized human
-NCIT2009;2639207.nxml;C1288;granulocyte-macrophage colony stimulating factor;55173;55221; the hematopoietic protein; (gm-csf) j cereb blood flow metab
+NCIT2009,2639207.nxml,C0376563,granulocyte-macrophage colony stimulating factor,55173,55221, the hematopoietic protein, (gm-csf) j cereb blood flow metab
-NCIT2009;2639550.nxml;C635;meperidine;11813;11823; as the use of; in oncology was minimal (14–43
+NCIT2009,2639550.nxml,C0353148,meperidine,11813,11823, as the use of, in oncology was minimal (14–43
-NCIT2009;2639605.nxml;C25284;type;8399;8403; fitzpatrick's classification of skin; was assessed for cases only,
+NCIT2009,2639605.nxml,C0332307,type,8399,8403, fitzpatrick's classification of skin," was assessed for cases only,"
-NCIT2009;2639689.nxml;C64858;protein;5690;5697; salt bridges between two; chains chosen from the user
+NCIT2009,2639689.nxml,C0555903,protein,5690,5697, salt bridges between two, chains chosen from the user
-NCIT2009;2639691.nxml;C459;medicine;16077;16085; an important ayurvedic;, which often promotes
+NCIT2009,2639691.nxml,C0013227,medicine,16077,16085, an important ayurvedic,", which often promotes"
-NCIT2009;2642848.nxml;C53837;pain;4943;4947; were the source of;. these included injection
+NCIT2009,2642848.nxml,C1882272,pain,4943,4947, were the source of,. these included injection
-NCIT2009;2642854.nxml;C73621;pre-existing;3064;3076; around an infected;" pseudodiverticulum; or a"
+NCIT2009,2642854.nxml,C2347662,pre-existing,3064,3076, around an infected, pseudodiverticulum; or a
-NCIT2009;2643463.nxml;C73399;liver;52705;52710; -glucuronidation in human; microsomes. biopharmaceutics and
+NCIT2009,2643463.nxml,C2346688,liver,52705,52710, -glucuronidation in human, microsomes. biopharmaceutics and
-NCIT2009;2643481.nxml;C52627;GTF3c1;17253;17259; domain only 2) and; (general transcript factor 3c1)
+NCIT2009,2643481.nxml,C1705412,GTF3c1,17253,17259, domain only 2) and, (general transcript factor 3c1)
-NCIT2009;2643483.nxml;C25247;negative;38779;38787; are discarded. as a; regulator of rice disease
+NCIT2009,2643483.nxml,C0205160,negative,38779,38787, are discarded. as a, regulator of rice disease
-NCIT2009;2643937.nxml;C16612;genes;24616;24621; the similar crms regulating the; in this focused subcluster. (b)
+NCIT2009,2643937.nxml,C0017337,genes,24616,24621, the similar crms regulating the, in this focused subcluster. (b)
-NCIT2009;2644311.nxml;C25387;benefits;17196;17204; are currently analysing the; and safety of tension
+NCIT2009,2644311.nxml,C0814225,benefits,17196,17204, are currently analysing the, and safety of tension
-NCIT2009;2644589.nxml;C25473;every day;15878;15887; reported engaging in vpa; of the week (n =
+NCIT2009,2644589.nxml,C0332173,every day,15878,15887, reported engaging in vpa, of the week (n =
-NCIT2009;2644604.nxml;C48294;Reference;42358;42367; have shopping malls 1 ;]
+NCIT2009,2644604.nxml,C1706462,Reference,42358,42367, have shopping malls 1 ,]
-NCIT2009;2644663.nxml;C69160;liters per minute;38477;38494; ) flow rate was 0.35 standard; (slm). the supporting air flow
+NCIT2009,2644663.nxml,C2346686,liters per minute,38477,38494, ) flow rate was 0.35 standard, (slm). the supporting air flow
-NCIT2009;2644687.nxml;C25737;identified;18195;18205; standard errors discussion we have; a frequent haplotype (haplotype 1)
+NCIT2009,2644687.nxml,C0205396,identified,18195,18205, standard errors discussion we have, a frequent haplotype (haplotype 1)
-NCIT2009;2644690.nxml;C21490;ubiquitin carboxy-terminal hydrolase;62081;62117; sydow o galter d s18y in; l1 (uch-l1) associated with
+NCIT2009,2644690.nxml,C1368335,ubiquitin carboxy-terminal hydrolase,62081,62117, sydow o galter d s18y in, l1 (uch-l1) associated with
-NCIT2009;2645359.nxml;C49463;second;7093;7099; due to its action on the ; messenger system known as
+NCIT2009,2645359.nxml,C1705190,second,7093,7099, due to its action on the , messenger system known as
-NCIT2009;2645691.nxml;C51055;MAGI-1;28060;28066; and dorsal is up.; was detected in the neurons
+NCIT2009,2645691.nxml,C1704462,MAGI-1,28060,28066, and dorsal is up., was detected in the neurons
-NCIT2009;2646017.nxml;C25361;performance;17325;17336; the impact of pay for; incentives on ethnic disparities
+NCIT2009,2646017.nxml,C0597198,performance,17325,17336, the impact of pay for, incentives on ethnic disparities
-NCIT2009;2646320.nxml;C25212;end-point;11988;11997; interventions. the primary; was duration of weaning,
+NCIT2009,2646320.nxml,C2349179,end-point,11988,11997, interventions. the primary," was duration of weaning,"
-NCIT2009;2646651.nxml;C28247;speech pathologist;13404;13422; further referred to medical;, ie, phoniatrician, at the
+NCIT2009,2646651.nxml,C0402015,speech pathologist,13404,13422, further referred to medical,", ie, phoniatrician, at the"
-NCIT2009;2646694.nxml;C52582;referral;4451;4459; in his cot, an urgent; was made to the
+NCIT2009,2646694.nxml,C0034927,referral,4451,4459," in his cot, an urgent", was made to the
-NCIT2009;2646790.nxml;C63537;study;238;243; animal experimental model to; the effects of levonorgestrel
+NCIT2009,2646790.nxml,C1880229,study,238,243, animal experimental model to, the effects of levonorgestrel
-NCIT2009;2647295.nxml;C2407;MUC1 mucin;19058;19068; used to confirm the expression of; on all cell lines tested
+NCIT2009,2647295.nxml,C0006611,MUC1 mucin,19058,19068, used to confirm the expression of, on all cell lines tested
-NCIT2009;2647692.nxml;C60730;interest;36837;36845; potential conflicts of; relevant to this
+NCIT2009,2647692.nxml,C0543488,interest,36837,36845, potential conflicts of, relevant to this
-NCIT2009;2647767.nxml;C25673;sequence;56060;56068; the repetitive nature of the; are indicated by blue numbers. (
+NCIT2009,2647767.nxml,C1519249,sequence,56060,56068, the repetitive nature of the, are indicated by blue numbers. (
-NCIT2009;2647780.nxml;C69128;R788;65529;65533; switch. curr biol 11; r791 11591339 12 bhalla us
+NCIT2009,2647780.nxml,C2348126,R788,65529,65533, switch. curr biol 11, r791 11591339 12 bhalla us
-NCIT2009;2648039.nxml;C49291;principle component analysis;27898;27926; colonies. for use in; (pca), the peak areas were
+NCIT2009,2648039.nxml,C0429865,principle component analysis,27898,27926, colonies. for use in," (pca), the peak areas were"
-NCIT2009;2648789.nxml;C17886;Meta-analysis;10658;10671; genetics replication and; consortium (diagram) have been published
+NCIT2009,2648789.nxml,C0920317,Meta-analysis,10658,10671, genetics replication and, consortium (diagram) have been published
-NCIT2009;2648799.nxml;C25474;data;1446;1450; large short sequence; sets. our solution uses
+NCIT2009,2648799.nxml,C1511726,data,1446,1450, large short sequence, sets. our solution uses
-NCIT2009;2649115.nxml;C37902;support;2633;2640; different display options to; visualization and utilization of
+NCIT2009,2649115.nxml,C1521721,support,2633,2640, different display options to, visualization and utilization of
-NCIT2009;2649127.nxml;C25338;score;18447;18452; linings and the combined; was divided by two. ¤: p
+NCIT2009,2649127.nxml,C0449820,score,18447,18452, linings and the combined, was divided by two. ¤: p
-NCIT2009;2649160.nxml;C28597;kinase;36605;36611; targeted disruption of glycerol; gene in mice: expression
+NCIT2009,2649160.nxml,C0031727,kinase,36605,36611, targeted disruption of glycerol, gene in mice: expression
-NCIT2009;2649160.nxml;C29077;glycerol;36596;36604; km targeted disruption of; kinase gene in mice:
+NCIT2009,2649160.nxml,C0017861,glycerol,36596,36604, km targeted disruption of, kinase gene in mice:
--- a/Direct Maintenance/DataSet_2010/snomedct_evolved_in_2010.csv
+++ b/Direct Maintenance/DataSet_2010/snomedct_evolved_in_2010.csv
-document	concept	annotation	start	end	kosAtt
+document,concept,annotation,start,end,kosAtt
-2630847.nxml	269934003	Microbiology	43328	43340	Microbiology
+2630847.nxml,C0085672,Microbiology,43328,43340,Microbiology
-2630851.nxml	37810007	Myeloid leukemia	27071	27087	Myeloid leukemia
+2630851.nxml,C0023470,Myeloid leukemia,27071,27087,Myeloid leukemia
-2630920.nxml	185527008	screening method	6574	6590	screening method
+2630920.nxml,C0422392,screening method,6574,6590,screening method
-2630927.nxml	71173004	Compression	12649	12660	Compression
+2630927.nxml,C0332459,Compression,12649,12660,Compression
-2630928.nxml	401173007	disease management programs	34297	34324	Disease management program
+2630928.nxml,C1303150,disease management programs,34297,34324,Disease management program
-2630928.nxml	230690007	stroke	10519	10525	Stroke
+2630928.nxml,C0038454,stroke,10519,10525,Stroke
-2630947.nxml	266474003	cholelithiasis	13526	13540	Cholelithiasis
+2630947.nxml,C0008350,cholelithiasis,13526,13540,Cholelithiasis
-2630959.nxml	64859006	osteoporosis	14225	14237	Osteoporosis
+2630959.nxml,C0029456,osteoporosis,14225,14237,Osteoporosis
-2630959.nxml	58214004	schizophrenia	4032	4045	Schizophrenia
+2630959.nxml,C0036341,schizophrenia,4032,4045,Schizophrenia
-2630962.nxml	33679000	vibration	4093	4102	Vibration
+2630962.nxml,C0459800,vibration,4093,4102,Vibration
-2630976.nxml	49049000	Parkinson's disease	1308	1327	Parkinson's disease
+2630976.nxml,C0030567,Parkinson's disease,1308,1327,Parkinson's disease
-2630978.nxml	57182000	Nerve injury	41596	41608	Nerve injury
+2630978.nxml,C0161479,Nerve injury,41596,41608,Nerve injury
-2630986.nxml	17450006	myoclonus	17004	17013	Myoclonus
+2630986.nxml,C0027066,myoclonus,17004,17013,Myoclonus
-2630986.nxml	410429000	cardiac arrest	20952	20966	Cardiac arrest
+2630986.nxml,C0018790,cardiac arrest,20952,20966,Cardiac arrest
-2630993.nxml	7793005	problems of the lower urinary tract	2962	2997	Disorder of the lower urinary tract
+2630993.nxml,C0268818,problems of the lower urinary tract,2962,2997,Disorder of the lower urinary tract
-2631025.nxml	84478008	occupational therapy	22527	22547	Occupational therapy
+2631025.nxml,C1318464,occupational therapy,22527,22547,Occupational therapy
-2631157.nxml	223357005	Armed Forces	625	637	Armed forces
+2631157.nxml,C0402580,Armed Forces,625,637,Armed forces
-2631192.nxml	44376007	hysteria	36944	36952	Hysteria
+2631192.nxml,C0020701,hysteria,36944,36952,Hysteria
-2631457.nxml	76976005	Optic atrophy	11537	11550	Optic atrophy
+2631457.nxml,C0029124,Optic atrophy,11537,11550,Optic atrophy
-2631490.nxml	43064006	Hydronephrosis	7055	7069	Hydronephrosis
+2631490.nxml,C0020295,Hydronephrosis,7055,7069,Hydronephrosis
-2631497.nxml	281255004	small bowel obstruction	13919	13942	Small bowel obstruction
+2631497.nxml,C0235329,small bowel obstruction,13919,13942,Small bowel obstruction
-2631515.nxml	181827008	vertebra c7	27835	27846	C7 vertebra
+2631515.nxml,C1306475,vertebra c7,27835,27846,C7 vertebra
-2631525.nxml	386556002	Tympanoplasty	16696	16709	Tympanoplasty
+2631525.nxml,C0041447,Tympanoplasty,16696,16709,Tympanoplasty
-2631537.nxml	219106009	attempted suicide	2931	2948	Attempted suicide
+2631537.nxml,C0038663,attempted suicide,2931,2948,Attempted suicide
-2631537.nxml	17369002	Spontaneous abortion	3676	3696	Spontaneous abortion
+2631537.nxml,C0000786,Spontaneous abortion,3676,3696,Spontaneous abortion
-2631893.nxml	3764006	Trichomonas	1233	1244	Trichomonas
+2631893.nxml,C0040919,Trichomonas,1233,1244,Trichomonas
-2632387.nxml	5294002	Developmental disorder	32020	32042	Developmental disorder
+2632387.nxml,C0008073,Developmental disorder,32020,32042,Developmental disorder
-2632390.nxml	308540004	Inpatient stay	23030	23044	Inpatient stay
+2632390.nxml,C0420512,Inpatient stay,23030,23044,Inpatient stay
-2632733.nxml	84172003	Spondylitis	17014	17025	Spondylitis
+2632733.nxml,C0038012,Spondylitis,17014,17025,Spondylitis
-2633157.nxml	40055000	Chronic sinusitis	5892	5909	Chronic sinusitis
+2633157.nxml,C0149516,Chronic sinusitis,5892,5909,Chronic sinusitis
-2633322.nxml	37373007	Meckel diverticulum	6405	6424	meckel diverticulum
+2633322.nxml,C0025037,Meckel diverticulum,6405,6424,meckel diverticulum
-2633339.nxml	46903006	Hydrotherapy	12979	12991	hydrotherapy
+2633339.nxml,C0020311,Hydrotherapy,12979,12991,hydrotherapy
-2633454.nxml	43075005	Partial colectomy	13206	13223	Partial colectomy
+2633454.nxml,C0149750,Partial colectomy,13206,13223,Partial colectomy
-2633454.nxml	385486001	Postoperative complication	8981	9007	Postoperative complication
+2633454.nxml,C0032787,Postoperative complication,8981,9007,Postoperative complication
-2634611.nxml	19471005	Lymphadenitis	18408	18421	lymphadenitis
+2634611.nxml,C0024205,Lymphadenitis,18408,18421,lymphadenitis
-2634615.nxml	309934006	division of Infectious Diseases	626	657	Infectious diseases department
+2634615.nxml,C0587472,division of Infectious Diseases,626,657,Infectious diseases department
-2634747.nxml	9707006	volvulus	12743	12751	Volvulus
+2634747.nxml,C0042961,volvulus,12743,12751,Volvulus
-2636021.nxml	399054005	exotropia	2282	2291	Exotropia
+2636021.nxml,C0015310,exotropia,2282,2291,Exotropia
-2636023.nxml	80093006	enophthalmos	5079	5091	Enophthalmos
+2636023.nxml,C0014306,enophthalmos,5079,5091,Enophthalmos
-2636167.nxml	43363007	posterior uveitis	12003	12020	Posterior uveitis
+2636167.nxml,C0042167,posterior uveitis,12003,12020,Posterior uveitis
-2636175.nxml	48677004	scarring	25098	25106	Scarring
+2636175.nxml,C2004491,scarring,25098,25106,Scarring
-2636754.nxml	81680005	neck pain	23435	23444	Neck pain
+2636754.nxml,C0007859,neck pain,23435,23444,Neck pain
-2636778.nxml	74728003	hypopituitarism	10421	10436	Hypopituitarism
+2636778.nxml,C0020635,hypopituitarism,10421,10436,Hypopituitarism
-2637092.nxml	388990007	synovectomy	9711	9722	Synovectomy
+2637092.nxml,C0185304,synovectomy,9711,9722,Synovectomy
-2637256.nxml	398050005	colonic diverticulosis	7679	7701	Diverticular disease of colon
+2637256.nxml,C0012819,colonic diverticulosis,7679,7701,Diverticular disease of colon
-2646717.nxml	260222006	single photon emission computed tomography	8820	8863	SPET - Single photon emission computed tomography
+2646717.nxml,C0040399,single photon emission computed tomography,8820,8862,SPET - Single photon emission computed tomography
-2646717.nxml	260222006	single photon emission computed tomography	8820	8862	SPET - Single photon emission computed tomography
+2634777.nxml,C0073386,Ringer solution,6027,6042,Ringer solution
-2634777.nxml	3221003	Ringer solution	6027	6042	Ringer solution
+2643102.nxml,C0003868,gouty arthritis,39777,39792,gouty arthritis
-2643102.nxml	48440001	gouty arthritis	39777	39792	gouty arthritis
+2645707.nxml,C0589368,postoperative myocardial infarction,54350,54385,postoperative myocardial infarction
-2645707.nxml	129574000	postoperative myocardial infarction	54350	54385	postoperative myocardial infarction
+2649137.nxml,C1269683,depression,27087,27097,depression
-2649137.nxml	35489007	depression	27087	27097	depression
+2643098.nxml,C0242490,Enthesopathy,3712,3724,Enthesopathy
-2643098.nxml	23680005	Enthesopathy	3712	3724	Enthesopathy
+2642994.nxml,C0191321,punch biopsy of skin,8046,8066,punch biopsy of skin
-2642994.nxml	87697008	punch biopsy of skin	8046	8066	punch biopsy of skin
--- a/Direct Maintenance/DataSet_2010/snomedct_impacted_in_2010.csv
+++ b/Direct Maintenance/DataSet_2010/snomedct_impacted_in_2010.csv
-document;concept;annotation;start;end
+document,concept,annotation,start,end
-2630847.nxml;168392001;Microbiology;43328;43340
+2630847.nxml,C0085672,Microbiology,43328,43340
-2630851.nxml;188743000;myeloid leukemia;27071;27087
+2630851.nxml,C0023470,myeloid leukemia,27071,27087
-2630920.nxml;185532009;screening method;6574;6590
+2630920.nxml,C0422392,screening method,6574,6590
-2630927.nxml;150740009;compression;12649;12660
+2630927.nxml,C0565514,compression,12649,12660
-2630928.nxml;394834005;management;34305;34315
+2630928.nxml,C1273870,management,34305,34315
-2630928.nxml;313267000;stroke;10519;10525
+2630928.nxml,C0038454,stroke,10519,10525
-2630947.nxml;197403005;cholelithiasis;13526;13540
+2630947.nxml,C0008350,cholelithiasis,13526,13540
-2630959.nxml;203440004;osteoporosis;14225;14237
+2630959.nxml,C0029456,osteoporosis,14225,14237
-2630959.nxml;154870000;schizophrenia;4032;4045
+2630959.nxml,C0036341,schizophrenia,4032,4045
-2630962.nxml;150839004;vibration;4093;4102
+2630962.nxml,C0455941,vibration,4093,4102
-2630976.nxml;192831003;Parkinson's disease;1308;1327
+2630976.nxml,C0030567,Parkinson's disease,1308,1327
-2630978.nxml;157658008;nerve injury;41596;41608
+2630978.nxml,C0161479,nerve injury,41596,41608
-2630986.nxml;267583001;myoclonus;17004;17013
+2630986.nxml,C0027066,myoclonus,17004,17013
-2630986.nxml;309810002;cardiac arrest;20952;20966
+2630986.nxml,C0018790,cardiac arrest,20952,20966
-2630993.nxml;181429003;lower urinary tract;2978;2997
+2630993.nxml,C0447570,lower urinary tract,2978,2997
-2631025.nxml;183346008;occupational therapy;22527;22547
+2631025.nxml,C1318464,occupational therapy,22527,22547
-2631157.nxml;136941000;Armed Forces;625;637
+2631157.nxml,C0402580,Armed Forces,625,637
-2631192.nxml;268629005;hysteria;36944;36952
+2631192.nxml,C0020701,hysteria,36944,36952
-2631457.nxml;194046007;Optic atrophy;11537;11550
+2631457.nxml,C0029124,Optic atrophy,11537,11550
-2631490.nxml;197791000;hydronephrosis;7055;7069
+2631490.nxml,C0020295,hydronephrosis,7055,7069
-2631497.nxml;235802005;small bowel obstruction;13919;13942
+2631497.nxml,C0235329,small bowel obstruction,13919,13942
-2631515.nxml;181852005;vertebra;27835;27843
+2631515.nxml,C0447984,vertebra,27835,27843
-2631525.nxml;172699008;Tympanoplasty;16696;16709
+2631525.nxml,C0585590,Tympanoplasty,16696,16709
-2631537.nxml;287187001;attempted suicide;2931;2948
+2631537.nxml,C0038663,attempted suicide,2931,2948
-2631537.nxml;198689000;spontaneous abortion;3676;3696
+2631537.nxml,C0000786,spontaneous abortion,3676,3696
-2631893.nxml;187206001;Trichomonas;1233;1244
+2631893.nxml,C0040921,Trichomonas,1233,1244
-2632387.nxml;192149001;developmental disorder;32020;32042
+2632387.nxml,C0008073,developmental disorder,32020,32042
-2632390.nxml;152042002;inpatient stay;23030;23044
+2632390.nxml,C0420512,inpatient stay,23030,23044
-2632733.nxml;202654007;Spondylitis;17014;17025
+2632733.nxml,C0038012,Spondylitis,17014,17025
-2633157.nxml;195792008;chronic sinusitis;5892;5909
+2633157.nxml,C0149516,chronic sinusitis,5892,5909
-2633322.nxml;31113003;diverticulum;6412;6424
+2633322.nxml,C0012817,diverticulum,6412,6424
-2633339.nxml;182626004;Hydrotherapy;12979;12991
+2633339.nxml,C0020311,Hydrotherapy,12979,12991
-2633454.nxml;174113006;Partial colectomy;13206;13223
+2633454.nxml,C0400031,Partial colectomy,13206,13223
-2633454.nxml;213302007;postoperative complication;8981;9007
+2633454.nxml,C0032787,postoperative complication,8981,9007
-2634611.nxml;287688007;lymphadenitis;18408;18421
+2634611.nxml,C0024205,lymphadenitis,18408,18421
-2634615.nxml;266171003;Infectious Diseases;638;657
+2634615.nxml,C0009450,Infectious Diseases,638,657
-2634747.nxml;197061002;volvulus;12743;12751
+2634747.nxml,C0042961,volvulus,12743,12751
-2636021.nxml;194098009;exotropia;2282;2291
+2636021.nxml,C0015310,exotropia,2282,2291
-2636023.nxml;194031000;enophthalmos;5079;5091
+2636023.nxml,C0014306,enophthalmos,5079,5091
-2636167.nxml;193451001;posterior uveitis;12003;12020
+2636167.nxml,C0042167,posterior uveitis,12003,12020
-2636175.nxml;255450007;scarring;25098;25106
+2636175.nxml,C2004491,scarring,25098,25106
-2636754.nxml;268078004;neck pain;23435;23444
+2636754.nxml,C0007859,neck pain,23435,23444
-2636778.nxml;237681002;hypopituitarism;10421;10436
+2636778.nxml,C0020635,hypopituitarism,10421,10436
-2637092.nxml;415695005;synovectomy;9711;9722
+2637092.nxml,C1532181,synovectomy,9711,9722
-2637256.nxml;197094004;diverticulosis;7687;7701
+2637256.nxml,C1510475,diverticulosis,7687,7701
-2646641.nxml;275998009;bone;50209;50213
+2646641.nxml,C0555828,bone,50209,50213
-2646717.nxml;146258003;Tomography;8852;8863
+2646717.nxml,C0040395,Tomography,8852,8863
-2646717.nxml;146281001;Computed Tomography;8843;8862
+2646717.nxml,C0040405,Computed Tomography,8843,8862
-2634777.nxml;77899000;solution;6034;6042
+2634777.nxml,C0525069,solution,6034,6042
-2643102.nxml;201672003;gouty arthritis;39777;39792
+2643102.nxml,C0003868,gouty arthritis,39777,39792
-2645707.nxml;311797004;postoperative myocardial infarction;54350;54385
+2645707.nxml,C0589368,postoperative myocardial infarction,54350,54385
-2649137.nxml;41006004;depression;27087;27097
+2649137.nxml,C0344315,depression,27087,27097
-2643098.nxml;202890003;Enthesopathy;3712;3724
+2643098.nxml,C0242490,Enthesopathy,3712,3724
-2642994.nxml;177345003;punch biopsy of skin;8046;8066
+2642994.nxml,C0191321,punch biopsy of skin,8046,8066
--- a/Direct Maintenance/DataSet_2010/snomedct_original_annot_in_2009.csv
+++ b/Direct Maintenance/DataSet_2010/snomedct_original_annot_in_2009.csv
--- a/Direct Maintenance/DataSet_2016/ncit_evolved_2016.csv
+++ b/Direct Maintenance/DataSet_2016/ncit_evolved_2016.csv
 document,concept,annotation,start,end,kosAtt
 2630847.nxml,C822,salt,31078,31082,Salt
 2630847.nxml,C29974,salt,31078,31086,Salt
 2630848.nxml,C51980,product,5675,5682,Product
 2630848.nxml,C40352,product,5675,5689,Product
 2630914.nxml,C48570,percent,21653,21660,percent
 2630943.nxml,C1741,an anion chloride,5556,5575,chloride
 2630944.nxml,C70713,Type of sample,25439,25453,Sample Type
 2630947.nxml,C64941,External Use,6663,6675,External Use
 2630960.nxml,C17041,public policy,34912,34925,Public Policy
 2630962.nxml,C12742,lower extremities,5309,5326,Lower Extremity
 2630962.nxml,C12742,the lower extremities,5305,5326,lower limb
 2630977.nxml,C35136,Peripheral Vascular Disease,21627,21654,Peripheral Vascular Disease
 2630978.nxml,C27221,nerve entrapment,17195,17211,Entrapment Neuropathy
 2630994.nxml,C75608,ikk gamma,10171,10180,ikk gamma
 2630997.nxml,C16508,DNA methyltransferases,4574,4596,DNA Methyltransferase
 2631011.nxml,C74934,labeling index,18554,18568,Labeling Index
 2631011.nxml,C18456,labeling index,18554,18568,Labeling Index
 2631072.nxml,C62071,primaquine,21778,21788,primaquine
 2631224.nxml,C73691,Dnmt3a,66061,66067,Dnmt3a
 2631224.nxml,C73652,Dnmt3a,66061,66067,Dnmt3a
 2631225.nxml,C62069,piperacillin,21547,21559,Piperacillin
 2631502.nxml,C1145,lignan,60674,60680,Lignan
 2631502.nxml,C1145,lignans,59899,59906,lignan
 2631593.nxml,C44175,input value,26505,26516,Parameter Value
 2633164.nxml,C64798,MCHC,9622,9626,Erythrocyte Mean Corpuscular Hemoglobin Concentration
 2633361.nxml,C50427,Retrograde Flow,1895,1910,Retrograde Flow
 2634707.nxml,C63590,folfox-4,18556,18564,FOLFOX-4 Regimen
 2634727.nxml,C20586,hematopoietic colony-stimulating factors,21443,21483,Colony-Stimulating Factors
 2634758.nxml,C497,fish oils,30069,30078,fish oil
 2635365.nxml,C2278,Inhibin Beta,26324,26336,Inhibin Beta
 2635601.nxml,C1685,trail Apo2L,17765,17776,APO2L/TRAIL
 2635603.nxml,C79876,microcrystalline Cellulose powders,24206,24240,cellulose powders
 2635670.nxml,C20533,TNF-related apoptosis-inducing ligand (trail),6646,6690,TNF-Related Apoptosis Inducing Ligand TRAIL
 2636027.nxml,C14316,Infective Agents,6474,6490,Infective Agent
 2636142.nxml,C66877,Indinavir,49821,49830,Indinavir
 2636761.nxml,C71252,blood gas analysis,9093,9111,Blood Gas Analysis
 2636825.nxml,C1397,protein e6,14844,14854,Protein E6
 2636825.nxml,C17520,protein e6,14844,14854,Protein E6
 2637848.nxml,C14421,inbred mouse strain,36467,36486,Inbred Mouse Strains
 2638874.nxml,C20545,granulocyte macrophage colony-stimulating factor,12191,12239,Granulocyte Macrophage Colony-Stimulating Factor
 2639026.nxml,C63662,beta-sitosterol,22334,22349,Beta-sitosterol
 2639207.nxml,C20545,granulocyte-macrophage colony stimulating factor,55173,55221,granulocyte-macrophage colony stimulating factor
 2639550.nxml,C71632,Meperidine,11813,11823,Meperidine
 2639605.nxml,C74563,fitzpatrick's classification of skin type,8362,8403,Fitzpatrick Classification Scale
 2639689.nxml,C17021,protein,5690,5697,Protein
 2642848.nxml,C21104,the source of pain,4929,4947,Pain Origin
 2642848.nxml,C21104,source of pain,4933,4947,Pain Origin
 2643463.nxml,C12392,liver,52705,52710,Liver
 2643481.nxml,C29681,GTF3C1,17253,17259,GTF3C1
 2643481.nxml,C20665,GTF3C1,17253,17259,GTF3C1
 2644663.nxml,C67388,Liters per Minute,38477,38494,Liter per Minute
 2644690.nxml,C21558,ubiquitin carboxy-terminal hydrolase,62081,62117,ubiquitin c-terminal hydrolase
 2644690.nxml,C21490,ubiquitin carboxy-terminal hydrolase,62081,62117,Ubiquitin Carboxyl-Terminal Hydrolase BAP1
 2646651.nxml,C19177,speech pathologist,13404,13422,speech pathologist
 2646790.nxml,C63536,study,238,243,study
 2647295.nxml,C2407,MUC1 mucin,19058,19068,MUC-1 Antigen
 2647780.nxml,C69128,R788,65529,65533,r788 sodium
 2648039.nxml,C49291,principle component analysis,27898,27926,Principal Component Analysis
 2649160.nxml,C75498,Glycerol Kinase Gene,36596,36616,Glycerol Kinase Gene
 2649160.nxml,C75499,Glycerol Kinase Gene,36596,36616,Glycerol Kinase Gene
 2638874.nxml,C20545,granulocyte-macrophage colony stimulating factor,12191,12239,granulocyte-macrophage colony stimulating factor
 2632676.nxml,C12602,Sperm,38681,38686,Sperm
 2648799.nxml,C47824,data sets,1446,1455,data set
 2644589.nxml,C25473,every day,15878,15887,every day
 2636806.nxml,C50414,required hospitalization,28291,28315,required hospitalization
 2634620.nxml,C65294,cefepime,6266,6274,cefepime
\ No newline at end of file
--- a/Direct Maintenance/DataSet_2016/ncit_impacted_2016.csv
+++ b/Direct Maintenance/DataSet_2016/ncit_impacted_2016.csv
 document,concept,annotation,start,end,kosAtt
-2630847.nxml,C72068,Salt,31078,31082,
+2630847.nxml,C0206136,Salt,31078,31082,
-2630848.nxml,C71610,product,5675,5682,
+2630848.nxml,C2347741,product,5675,5682,
-2630914.nxml,C25613,percent,21653,21660,
+2630914.nxml,C0439165,percent,21653,21660,
-2630943.nxml,C68244,chloride,5565,5573,
+2630943.nxml,C0008203,chloride,5565,5573,
-2630944.nxml,C53193,Type of sample,25439,25453,
+2630944.nxml,C0449370,Type of sample,25439,25453,
-2630947.nxml,C65038,external use,6663,6675,
+2630947.nxml,C1882285,external use,6663,6675,
-2630960.nxml,C17735,public policy,34912,34925,
+2630960.nxml,C0034033,public policy,34912,34925,
-2630962.nxml,C30140,extremities,5315,5326,
+2630962.nxml,C0015385,extremities,5315,5326,
-2630977.nxml,C50694,peripheral vascular disease,21627,21654,
+2630977.nxml,C0085096,peripheral vascular disease,21627,21654,
-2630978.nxml,C50548,entrapment,17201,17211,
+2630978.nxml,C1962925,entrapment,17201,17211,
-2631502.nxml,C68494,lignan,60674,60680,
+2631502.nxml,C2346673,lignan,60674,60680,
-2633361.nxml,C73500,retrograde flow,1895,1910,
+2633361.nxml,C2347959,retrograde flow,1895,1910,
-2635601.nxml,C1685,Apo2L,17771,17776,
+2635601.nxml,C1522480,Apo2L,17771,17776,
-2635670.nxml,C1685,TNF-related apoptosis-inducing ligand,6646,6683,
+2635670.nxml,C1522480,TNF-related apoptosis-inducing ligand,6646,6683,
-2636027.nxml,C50922,infective agents,6474,6490,
+2636027.nxml,C0450254,infective agents,6474,6490,
-2636142.nxml,C1662,indinavir,49821,49830,
+2636142.nxml,C0700483,indinavir,49821,49830,
-2637848.nxml,C14421,inbred mouse,36467,36479,
+2637848.nxml,C1512690,inbred mouse,36467,36479,
-2639026.nxml,C68324,beta-sitosterol,22334,22349,
+2639026.nxml,C0106127,beta-sitosterol,22334,22349,
-2639550.nxml,C635,meperidine,11813,11823,
+2639550.nxml,C0353148,meperidine,11813,11823,
-2639689.nxml,C64858,protein,5690,5697,
+2639689.nxml,C0555903,protein,5690,5697,
-2642848.nxml,C53837,pain,4943,4947,
+2642848.nxml,C1882272,pain,4943,4947,
-2643463.nxml,C73399,liver,52705,52710,
+2643463.nxml,C2346688,liver,52705,52710,
-2644663.nxml,C69160,liters per minute,38477,38494,
+2644663.nxml,C2346686,liters per minute,38477,38494,
-2646651.nxml,C28247,speech pathologist,13404,13422,
+2646651.nxml,C0402015,speech pathologist,13404,13422,
-2646790.nxml,C63537,study,238,243,
+2646790.nxml,C1880229,study,238,243,
-2630994.nxml,C68914,gamma,10175,10180,
+2630994.nxml,C2349976,gamma,10175,10180,
-2631011.nxml,C54694,labeling,18554,18562,
+2631011.nxml,C1947902,labeling,18554,18562,
-2631011.nxml,C25390,index,18563,18568,
+2631011.nxml,C0918012,index,18563,18568,
-2634707.nxml,C11197,FOLFOX,18556,18562,
+2634707.nxml,C0392943,FOLFOX,18556,18562,
-2634727.nxml,C1288,hematopoietic colony-stimulating factors,21443,21483,
+2634727.nxml,C0376563,hematopoietic colony-stimulating factors,21443,21483,
-2635365.nxml,C1349,Inhibin beta,26324,26336,
+2635365.nxml,C1527008,Inhibin beta,26324,26336,
-2635603.nxml,C68491,Cellulose,24223,24232,
+2635603.nxml,C0007648,Cellulose,24223,24232,
-2636761.nxml,C12434,blood,9093,9098,
+2636761.nxml,C0229664,blood,9093,9098,
-2636825.nxml,C41172,protein,14844,14851,
+2636825.nxml,C1521746,protein,14844,14851,
-2638874.nxml,C1288,granulocyte macrophage colony-stimulating factor,12191,12239,
+2638874.nxml,C0376563,granulocyte macrophage colony-stimulating factor,12191,12239,
-2639207.nxml,C1288,granulocyte-macrophage colony stimulating factor,55173,55221,
+2639207.nxml,C0376563,granulocyte-macrophage colony stimulating factor,55173,55221,
-2639605.nxml,C25284,type,8399,8403,
+2639605.nxml,C0332307,type,8399,8403,
-2642848.nxml,C53837,pain,4943,4947,
+2642848.nxml,C1882272,pain,4943,4947,
-2643481.nxml,C52627,GTF3c1,17253,17259,
+2643481.nxml,C1705412,GTF3c1,17253,17259,
-2648799.nxml,C25474,data,1446,1450,
+2648799.nxml,C1511726,data,1446,1450,
-2649160.nxml,C28597,kinase,36605,36611,
+2649160.nxml,C0031727,kinase,36605,36611,
-2649160.nxml,C29077,glycerol,36596,36604,
+2649160.nxml,C0017861,glycerol,36596,36604,
-2630997.nxml,C16508,DNA methyltransferases,4574,4596,
+2630997.nxml,C0012873,DNA methyltransferases,4574,4596,
-2631224.nxml,C73653,Dnmt3a,66061,66067,
+2631224.nxml,C2348050,Dnmt3a,66061,66067,
-2631225.nxml,C749,piperacillin,21547,21559,
+2631225.nxml,C0031955,piperacillin,21547,21559,
-2631502.nxml,C1145,lignans,59899,59906,
+2631502.nxml,C0064971,lignans,59899,59906,
-2631593.nxml,C44175,input value,26505,26516,
+2631593.nxml,C0549193,input value,26505,26516,
-2633164.nxml,C64798,MCHC,9622,9626,
+2633164.nxml,C0474535,MCHC,9622,9626,
-2634758.nxml,C497,fish oils,30069,30078,
+2634758.nxml,C0016157,fish oils,30069,30078,
-2644690.nxml,C21490,ubiquitin carboxy-terminal hydrolase,62081,62117,
+2644690.nxml,C1368335,ubiquitin carboxy-terminal hydrolase,62081,62117,
-2647295.nxml,C2407,MUC1 mucin,19058,19068,
+2647295.nxml,C0006611,MUC1 mucin,19058,19068,
-2647780.nxml,C69128,R788,65529,65533,
+2647780.nxml,C2348126,R788,65529,65533,
-2648039.nxml,C49291,principle component analysis,27898,27926,
+2648039.nxml,C0429865,principle component analysis,27898,27926,
-2631072.nxml,C771,primaquine,21778,21788,
+2631072.nxml,C0033126,primaquine,21778,21788,
-2638874.nxml,C1288,granulocyte-macrophage colony stimulating factor,12191,12239,
+2638874.nxml,C0376563,granulocyte-macrophage colony stimulating factor,12191,12239,
-2632676.nxml,C12602,Sperm,38681,38686,
+2632676.nxml,C0037868,Sperm,38681,38686,
-2644589.nxml,C25473,every day,15878,15887,
+2644589.nxml,C0332173,every day,15878,15887,
-2636806.nxml,C50414,required hospitalization,28291,28315,
+2636806.nxml,C1708385,required hospitalization,28291,28315,
-2634620.nxml,C1041,cefepime,6266,6274,
+2634620.nxml,C0771284,cefepime,6266,6274,
\ No newline at end of file
--- a/Direct Maintenance/DataSet_2016/ncit_original_2009.csv
+++ b/Direct Maintenance/DataSet_2016/ncit_original_2009.csv
-kos;document;concept;sentence;startOffset;endOffset;prefix;sufix
+kos,document,concept,sentence,startOffset,endOffset,prefix,sufix
-NCIT2009;2630847.nxml;C72068;Salt;31078;31082; p new nectriapyrones by; water culture of a fungus
+NCIT2009,2630847.nxml,C0206136,Salt,31078,31082, p new nectriapyrones by, water culture of a fungus
-NCIT2009;2630848.nxml;C71610;product;5675;5682; yielded 3 as the main;. compound 3 possesses a
+NCIT2009,2630848.nxml,C2347741,product,5675,5682, yielded 3 as the main,. compound 3 possesses a
-NCIT2009;2630914.nxml;C25613;percent;21653;21660; transcript abundances. twenty-two; of the genes in cluster
+NCIT2009,2630914.nxml,C0439165,percent,21653,21660, transcript abundances. twenty-two, of the genes in cluster
-NCIT2009;2630943.nxml;C68244;chloride;5565;5573; encodes an anion ;/iodide) transporter
+NCIT2009,2630943.nxml,C0008203,chloride,5565,5573, encodes an anion ,/iodide) transporter
-NCIT2009;2630944.nxml;C53193;Type of sample;25439;25453; by reducing variance. iv.; dna, rna and protein
+NCIT2009,2630944.nxml,C0449370,Type of sample,25439,25453, by reducing variance. iv.," dna, rna and protein"
-NCIT2009;2630947.nxml;C65038;external use;6663;6675; used as oral administration or;. in treating conjunctivitis
+NCIT2009,2630947.nxml,C1882285,external use,6663,6675, used as oral administration or,. in treating conjunctivitis
-NCIT2009;2630960.nxml;C17735;public policy;34912;34925; survey data to inform;: comparison of
+NCIT2009,2630960.nxml,C0034033,public policy,34912,34925, survey data to inform,: comparison of
-NCIT2009;2630962.nxml;C30140;extremities;5315;5326; assessment of the lower;. body constitution is
+NCIT2009,2630962.nxml,C0015385,extremities,5315,5326, assessment of the lower,. body constitution is
-NCIT2009;2630977.nxml;C50694;peripheral vascular disease;21627;21654; pressure, heart disease,;, diabetes, focal
+NCIT2009,2630977.nxml,C0085096,peripheral vascular disease,21627,21654," pressure, heart disease,",", diabetes, focal"
-NCIT2009;2630978.nxml;C50548;entrapment;17201;17211; after sciatic nerve; (sne) sne is a variation
+NCIT2009,2630978.nxml,C1962925,entrapment,17201,17211, after sciatic nerve, (sne) sne is a variation
-NCIT2009;2630994.nxml;C68914;gamma;10175;10180; to mutations in ikk; (nemo) am j hum genet 2000
+NCIT2009,2630994.nxml,C2349976,gamma,10175,10180, to mutations in ikk, (nemo) am j hum genet 2000
-NCIT2009;2630997.nxml;C16508;DNA methyltransferases;4574;4596; together with; (mtases) of the same or
+NCIT2009,2630997.nxml,C0012873,DNA methyltransferases,4574,4596, together with, (mtases) of the same or
-NCIT2009;2631011.nxml;C54694;labeling;18554;18562; tumors above the median; index were categorized as
+NCIT2009,2631011.nxml,C1947902,labeling,18554,18562, tumors above the median, index were categorized as
-NCIT2009;2631011.nxml;C25390;index;18563;18568; above the median labeling; were categorized as high ki-67
+NCIT2009,2631011.nxml,C0918012,index,18563,18568, above the median labeling, were categorized as high ki-67
-NCIT2009;2631072.nxml;C771;primaquine;21778;21788; treating the cell with; (pmq), a receptor recycling
+NCIT2009,2631072.nxml,C0033126,primaquine,21778,21788, treating the cell with," (pmq), a receptor recycling"
-NCIT2009;2631131.nxml;C16428;China;938;943; of;, beijing,
+NCIT2009,2631131.nxml,C0008115,China,938,943, of,", beijing,"
-NCIT2009;2631224.nxml;C73653;Dnmt3a;66061;66067; n kasai m kouzarides t; binds deacetylases and is
+NCIT2009,2631224.nxml,C2348050,Dnmt3a,66061,66067, n kasai m kouzarides t, binds deacetylases and is
-NCIT2009;2631225.nxml;C749;piperacillin;21547;21559; with cefepim, meropenem,; and gentamicin against
+NCIT2009,2631225.nxml,C0031955,piperacillin,21547,21559," with cefepim, meropenem,", and gentamicin against
-NCIT2009;2631502.nxml;C1145;lignans;59899;59906; dna sequence-selective plant; proc natl acad sci usa
+NCIT2009,2631502.nxml,C0064971,lignans,59899,59906, dna sequence-selective plant, proc natl acad sci usa
-NCIT2009;2631502.nxml;C68494;lignan;60674;60680; nordihydroguaiaretic acid plant; derivatives antiviral research 2000
+NCIT2009,2631502.nxml,C2346673,lignan,60674,60680, nordihydroguaiaretic acid plant, derivatives antiviral research 2000
-NCIT2009;2631587.nxml;C16612;genes;55606;55611; the induction of p53 target; by sxr activators in cells
+NCIT2009,2631587.nxml,C0017337,genes,55606,55611, the induction of p53 target, by sxr activators in cells
-NCIT2009;2631593.nxml;C44175;input value;26505;26516; false discovery rate (fdr); (herein set to 0.01) or
+NCIT2009,2631593.nxml,C0549193,input value,26505,26516, false discovery rate (fdr), (herein set to 0.01) or
-NCIT2009;2632676.nxml;C12602;Sperm;38681;38686; 307 313 10714886 parker g; competition and its
+NCIT2009,2632676.nxml,C0037868,Sperm,38681,38686, 307 313 10714886 parker g, competition and its
-NCIT2009;2632756.nxml;C16351;Biotechnology;988;1001; of life sciences and;, shanghai jiao
+NCIT2009,2632756.nxml,C0005574,Biotechnology,988,1001, of life sciences and,", shanghai jiao"
-NCIT2009;2633046.nxml;C45281;object;2705;2711; with the ucs. pre-exposure to; distress increased the freezing 
+NCIT2009,2633046.nxml,C0347997,object,2705,2711, with the ucs. pre-exposure to, distress increased the freezing 
-NCIT2009;2633164.nxml;C64798;MCHC;9622;9626; (p<.05). the mcv, mch,; and ferritin levels were
+NCIT2009,2633164.nxml,C0474535,MCHC,9622,9626," (p<.05). the mcv, mch,", and ferritin levels were
-NCIT2009;2633361.nxml;C73500;retrograde flow;1895;1910; double syndrome as; in the right vertebral artery
+NCIT2009,2633361.nxml,C2347959,retrograde flow,1895,1910, double syndrome as, in the right vertebral artery
-NCIT2009;2634620.nxml;C1041;cefepime;6266;6274; cephalosporins,;, imipenem,
+NCIT2009,2634620.nxml,C0771284,cefepime,6266,6274," cephalosporins,",", imipenem,"
-NCIT2009;2634691.nxml;C16311;Australia;11814;11823; (invitrogen corporation, melbourne,;) in the presence of
+NCIT2009,2634691.nxml,C0004340,Australia,11814,11823," (invitrogen corporation, melbourne,",) in the presence of
-NCIT2009;2634703.nxml;C15313;irradiation;43767;43778; cell lines. combination of; and 17-aag induced a higher
+NCIT2009,2634703.nxml,C1522449,irradiation,43767,43778, cell lines. combination of, and 17-aag induced a higher
-NCIT2009;2634707.nxml;C11197;FOLFOX;18556;18562; addition of cetuximab to;-4 had a detrimental
+NCIT2009,2634707.nxml,C0392943,FOLFOX,18556,18562, addition of cetuximab to,-4 had a detrimental
-NCIT2009;2634727.nxml;C1288;hematopoietic colony-stimulating factors;21443;21483; for the use of;: evidence-based, clinical
+NCIT2009,2634727.nxml,C0376563,hematopoietic colony-stimulating factors,21443,21483, for the use of,": evidence-based, clinical"
-NCIT2009;2634758.nxml;C497;fish oils;30069;30078; of arrhythmias by n-3; circulation 2003 107 2646
+NCIT2009,2634758.nxml,C0016157,fish oils,30069,30078, of arrhythmias by n-3, circulation 2003 107 2646
-NCIT2009;2634779.nxml;C18635;area;22000;22004; of bone; and bone volume values has
+NCIT2009,2634779.nxml,C1510751,area,22000,22004, of bone, and bone volume values has
-NCIT2009;2635365.nxml;C1349;Inhibin beta;26324;26336; expression was observed for; e chain (inhbe), a
+NCIT2009,2635365.nxml,C1527008,Inhibin beta,26324,26336, expression was observed for," e chain (inhbe), a"
-NCIT2009;2635601.nxml;C1685;Apo2L;17771;17776; inducing ligand (trail;) and genistein is
+NCIT2009,2635601.nxml,C1522480,Apo2L,17771,17776, inducing ligand (trail,) and genistein is
-NCIT2009;2635603.nxml;C68491;Cellulose;24223;24232; variations of microcrystalline; powders powder techn 1998 98
+NCIT2009,2635603.nxml,C0007648,Cellulose,24223,24232, variations of microcrystalline, powders powder techn 1998 98
-NCIT2009;2635670.nxml;C1685;TNF-related apoptosis-inducing ligand;6646;6683; necrosis factor (tnf) receptor,; (trail) receptor and fas
+NCIT2009,2635670.nxml,C1522480,TNF-related apoptosis-inducing ligand,6646,6683," necrosis factor (tnf) receptor,", (trail) receptor and fas
-NCIT2009;2635670.nxml;C12508;Cell;30244;30248; bcl-2 protein family exp; res 2000 256 1 50
+NCIT2009,2635670.nxml,C0007634,Cell,30244,30248, bcl-2 protein family exp, res 2000 256 1 50
-NCIT2009;2635709.nxml;C48058;energy;32230;32236; force by spending the; indicated as
+NCIT2009,2635709.nxml,C0542479,energy,32230,32236, force by spending the, indicated as
-NCIT2009;2635739.nxml;C42768;role;36761;36765; precise structural layout and; of the capillary and
+NCIT2009,2635739.nxml,C1705809,role,36761,36765, precise structural layout and, of the capillary and
-NCIT2009;2635953.nxml;C15206;study;22001;22006; women. 27 another; concluded that, while there
+NCIT2009,2635953.nxml,C0008972,study,22001,22006, women. 27 another," concluded that, while there"
-NCIT2009;2636027.nxml;C50922;infective agents;6474;6490; the most common;, the necrotic base of
+NCIT2009,2636027.nxml,C0450254,infective agents,6474,6490, the most common,", the necrotic base of"
-NCIT2009;2636142.nxml;C1662;indinavir;49821;49830; to years after starting; therapy have also been
+NCIT2009,2636142.nxml,C0700483,indinavir,49821,49830, to years after starting, therapy have also been
-NCIT2009;2636761.nxml;C12434;blood;9093;9098; results from arterial; gas analysis (ph, pao2)
+NCIT2009,2636761.nxml,C0229664,blood,9093,9098, results from arterial," gas analysis (ph, pao2)"
-NCIT2009;2636763.nxml;C459;medication;21711;21721; and mean dose of hypnotic;. patients will also keep
+NCIT2009,2636763.nxml,C0013227,medication,21711,21721, and mean dose of hypnotic,. patients will also keep
-NCIT2009;2636806.nxml;C50414;required hospitalization;28291;28315; level of sickness that; would be a deterring
+NCIT2009,2636806.nxml,C1708385,required hospitalization,28291,28315, level of sickness that, would be a deterring
-NCIT2009;2636825.nxml;C41172;protein;14844;14851; lesions. they identified; e6 and -7 in six of
+NCIT2009,2636825.nxml,C1521746,protein,14844,14851, lesions. they identified, e6 and -7 in six of
-NCIT2009;2636833.nxml;C66836;five;8701;8705; that were larger than; years in the original
+NCIT2009,2636833.nxml,C0205451,five,8701,8705, that were larger than, years in the original
-NCIT2009;2637428.nxml;C64917;affected;23813;23821; and removal of injured or; cells [reviewed in 31]
+NCIT2009,2637428.nxml,C0392760,affected,23813,23821, and removal of injured or, cells [reviewed in 31]
-NCIT2009;2637848.nxml;C14421;inbred mouse;36467;36479; this strain background. the; strain carrying the mutation
+NCIT2009,2637848.nxml,C1512690,inbred mouse,36467,36479, this strain background. the, strain carrying the mutation
-NCIT2009;2638200.nxml;C70813;voltage;37255;37262; effects of ?1 on the;#NAME?
+NCIT2009,2638200.nxml,C0598352,voltage,37255,37262, effects of ?1 on the,#NAME?
-NCIT2009;2638874.nxml;C1288;granulocyte-macrophage colony stimulating factor;12191;12239; in vitro culture in murine; (100 ng ml ?1 
+NCIT2009,2638874.nxml,C0376563,granulocyte-macrophage colony stimulating factor,12191,12239, in vitro culture in murine, (100 ng ml ?1 
-NCIT2009;2639026.nxml;C68324;beta-sitosterol;22334;22349; triterpene alcohols with; the most abundant
+NCIT2009,2639026.nxml,C0106127,beta-sitosterol,22334,22349, triterpene alcohols with, the most abundant
-NCIT2009;2639035.nxml;C25300;culture;43539;43546; 17. milyavsky m prolonged; of telomerase-immortalized human
+NCIT2009,2639035.nxml,C0430400,culture,43539,43546, 17. milyavsky m prolonged, of telomerase-immortalized human
-NCIT2009;2639207.nxml;C1288;granulocyte-macrophage colony stimulating factor;55173;55221; the hematopoietic protein; (gm-csf) j cereb blood flow metab
+NCIT2009,2639207.nxml,C0376563,granulocyte-macrophage colony stimulating factor,55173,55221, the hematopoietic protein, (gm-csf) j cereb blood flow metab
-NCIT2009;2639550.nxml;C635;meperidine;11813;11823; as the use of; in oncology was minimal (14–43
+NCIT2009,2639550.nxml,C0353148,meperidine,11813,11823, as the use of, in oncology was minimal (14–43
-NCIT2009;2639605.nxml;C25284;type;8399;8403; fitzpatrick's classification of skin; was assessed for cases only,
+NCIT2009,2639605.nxml,C0332307,type,8399,8403, fitzpatrick's classification of skin," was assessed for cases only,"
-NCIT2009;2639689.nxml;C64858;protein;5690;5697; salt bridges between two; chains chosen from the user
+NCIT2009,2639689.nxml,C0555903,protein,5690,5697, salt bridges between two, chains chosen from the user
-NCIT2009;2639691.nxml;C459;medicine;16077;16085; an important ayurvedic;, which often promotes
+NCIT2009,2639691.nxml,C0013227,medicine,16077,16085, an important ayurvedic,", which often promotes"
-NCIT2009;2642848.nxml;C53837;pain;4943;4947; were the source of;. these included injection
+NCIT2009,2642848.nxml,C1882272,pain,4943,4947, were the source of,. these included injection
-NCIT2009;2642854.nxml;C73621;pre-existing;3064;3076; around an infected; pseudodiverticulum
+NCIT2009,2642854.nxml,C2347662,pre-existing,3064,3076, around an infected, pseudodiverticulum
-NCIT2009;2643463.nxml;C73399;liver;52705;52710; -glucuronidation in human; microsomes. biopharmaceutics and
+NCIT2009,2643463.nxml,C2346688,liver,52705,52710, -glucuronidation in human, microsomes. biopharmaceutics and
-NCIT2009;2643481.nxml;C52627;GTF3c1;17253;17259; domain only 2) and; (general transcript factor 3c1)
+NCIT2009,2643481.nxml,C1705412,GTF3c1,17253,17259, domain only 2) and, (general transcript factor 3c1)
-NCIT2009;2643483.nxml;C25247;negative;38779;38787; are discarded. as a; regulator of rice disease
+NCIT2009,2643483.nxml,C0205160,negative,38779,38787, are discarded. as a, regulator of rice disease
-NCIT2009;2643937.nxml;C16612;genes;24616;24621; the similar crms regulating the; in this focused subcluster. (b)
+NCIT2009,2643937.nxml,C0017337,genes,24616,24621, the similar crms regulating the, in this focused subcluster. (b)
-NCIT2009;2644311.nxml;C25387;benefits;17196;17204; are currently analysing the; and safety of tension
+NCIT2009,2644311.nxml,C0814225,benefits,17196,17204, are currently analysing the, and safety of tension
-NCIT2009;2644589.nxml;C25473;every day;15878;15887; reported engaging in vpa; of the week (n =
+NCIT2009,2644589.nxml,C0332173,every day,15878,15887, reported engaging in vpa, of the week (n =
-NCIT2009;2644604.nxml;C48294;Reference;42358;42367; have shopping malls 1 ;]
+NCIT2009,2644604.nxml,C1706462,Reference,42358,42367, have shopping malls 1 ,]
-NCIT2009;2644663.nxml;C69160;liters per minute;38477;38494; ) flow rate was 0.35 standard; (slm). the supporting air flow
+NCIT2009,2644663.nxml,C2346686,liters per minute,38477,38494, ) flow rate was 0.35 standard, (slm). the supporting air flow
-NCIT2009;2644687.nxml;C25737;identified;18195;18205; standard errors discussion we have; a frequent haplotype (haplotype 1)
+NCIT2009,2644687.nxml,C0205396,identified,18195,18205, standard errors discussion we have, a frequent haplotype (haplotype 1)
-NCIT2009;2644690.nxml;C21490;ubiquitin carboxy-terminal hydrolase;62081;62117; sydow o galter d s18y in; l1 (uch-l1) associated with
+NCIT2009,2644690.nxml,C1368335,ubiquitin carboxy-terminal hydrolase,62081,62117, sydow o galter d s18y in, l1 (uch-l1) associated with
-NCIT2009;2645359.nxml;C49463;second;7093;7099; due to its action on the ; messenger system known as
+NCIT2009,2645359.nxml,C1705190,second,7093,7099, due to its action on the , messenger system known as
-NCIT2009;2645691.nxml;C51055;MAGI-1;28060;28066; and dorsal is up.; was detected in the neurons
+NCIT2009,2645691.nxml,C1704462,MAGI-1,28060,28066, and dorsal is up., was detected in the neurons
-NCIT2009;2646017.nxml;C25361;performance;17325;17336; the impact of pay for; incentives on ethnic disparities
+NCIT2009,2646017.nxml,C0597198,performance,17325,17336, the impact of pay for, incentives on ethnic disparities
-NCIT2009;2646320.nxml;C25212;end-point;11988;11997; interventions. the primary; was duration of weaning,
+NCIT2009,2646320.nxml,C2349179,end-point,11988,11997, interventions. the primary," was duration of weaning,"
-NCIT2009;2646651.nxml;C28247;speech pathologist;13404;13422; further referred to medical;, ie, phoniatrician, at the
+NCIT2009,2646651.nxml,C0402015,speech pathologist,13404,13422, further referred to medical,", ie, phoniatrician, at the"
-NCIT2009;2646694.nxml;C52582;referral;4451;4459; in his cot, an urgent; was made to the
+NCIT2009,2646694.nxml,C0034927,referral,4451,4459," in his cot, an urgent", was made to the
-NCIT2009;2646790.nxml;C63537;study;238;243; animal experimental model to; the effects of levonorgestrel
+NCIT2009,2646790.nxml,C1880229,study,238,243, animal experimental model to, the effects of levonorgestrel
-NCIT2009;2647295.nxml;C2407;MUC1 mucin;19058;19068; used to confirm the expression of; on all cell lines tested
+NCIT2009,2647295.nxml,C0006611,MUC1 mucin,19058,19068, used to confirm the expression of, on all cell lines tested
-NCIT2009;2647692.nxml;C60730;interest;36837;36845; potential conflicts of; relevant to this
+NCIT2009,2647692.nxml,C0543488,interest,36837,36845, potential conflicts of, relevant to this
-NCIT2009;2647767.nxml;C25673;sequence;56060;56068; the repetitive nature of the; are indicated by blue numbers. (
+NCIT2009,2647767.nxml,C1519249,sequence,56060,56068, the repetitive nature of the, are indicated by blue numbers. (
-NCIT2009;2647780.nxml;C69128;R788;65529;65533; switch. curr biol 11; r791 11591339 12 bhalla us
+NCIT2009,2647780.nxml,C2348126,R788,65529,65533, switch. curr biol 11, r791 11591339 12 bhalla us
-NCIT2009;2648039.nxml;C49291;principle component analysis;27898;27926; colonies. for use in; (pca), the peak areas were
+NCIT2009,2648039.nxml,C0429865,principle component analysis,27898,27926, colonies. for use in," (pca), the peak areas were"
-NCIT2009;2648789.nxml;C17886;Meta-analysis;10658;10671; genetics replication and; consortium (diagram) have been published
+NCIT2009,2648789.nxml,C0920317,Meta-analysis,10658,10671, genetics replication and, consortium (diagram) have been published
-NCIT2009;2648799.nxml;C25474;data;1446;1450; large short sequence; sets. our solution uses
+NCIT2009,2648799.nxml,C1511726,data,1446,1450, large short sequence, sets. our solution uses
-NCIT2009;2649115.nxml;C37902;support;2633;2640; different display options to; visualization and utilization of
+NCIT2009,2649115.nxml,C1521721,support,2633,2640, different display options to, visualization and utilization of
-NCIT2009;2649127.nxml;C25338;score;18447;18452; linings and the combined; was divided by two. ¤: p
+NCIT2009,2649127.nxml,C0449820,score,18447,18452, linings and the combined, was divided by two. ¤: p
-NCIT2009;2649160.nxml;C28597;kinase;36605;36611; targeted disruption of glycerol; gene in mice: expression
+NCIT2009,2649160.nxml,C0031727,kinase,36605,36611, targeted disruption of glycerol, gene in mice: expression
-NCIT2009;2649160.nxml;C29077;glycerol;36596;36604; km targeted disruption of; kinase gene in mice:
+NCIT2009,2649160.nxml,C0017861,glycerol,36596,36604, km targeted disruption of, kinase gene in mice:
--- a/Direct Maintenance/DataSet_2016/snomedct_evolved_2016.csv
+++ b/Direct Maintenance/DataSet_2016/snomedct_evolved_2016.csv
 document,concept,annotation,start,end,kosAtt
-2630847.nxml,269934003,Microbiology,43328,43340,Microbiology
+2630847.nxml,C0085672,Microbiology,43328,43340,Microbiology
-2630849.nxml,281647001,adverse effects,2874,2889,adverse reaction
+2630849.nxml,C0559546,adverse effects,2874,2889,adverse reaction
-2630851.nxml,37810007,Myeloid leukemia,27071,27087,Myeloid leukemia
+2630851.nxml,C0023470,Myeloid leukemia,27071,27087,Myeloid leukemia
-2630920.nxml,185527008,screening method,6574,6590,screening method
+2630920.nxml,C0422392,screening method,6574,6590,screening method
-2630928.nxml,401173007,disease management programs,34297,34324,Disease management program
+2630928.nxml,C1303150,disease management programs,34297,34324,Disease management program
-2630928.nxml,230690007,stroke,10519,10525,Stroke
+2630928.nxml,C0038454,stroke,10519,10525,Stroke
-2630947.nxml,266474003,cholelithiasis,13526,13540,Cholelithiasis
+2630947.nxml,C0008350,cholelithiasis,13526,13540,Cholelithiasis
-2630959.nxml,64859006,osteoporosis,14225,14237,Osteoporosis
+2630959.nxml,C0029456,osteoporosis,14225,14237,Osteoporosis
-2630959.nxml,58214004,schizophrenia,4032,4045,Schizophrenia
+2630959.nxml,C0036341,schizophrenia,4032,4045,Schizophrenia
-2630962.nxml,33679000,vibration,4093,4102,Vibration
+2630962.nxml,C0459800,vibration,4093,4102,Vibration
-2630976.nxml,49049000,Parkinson's disease,1308,1327,Parkinson's disease
+2630976.nxml,C0030567,Parkinson's disease,1308,1327,Parkinson's disease
-2630978.nxml,57182000,Nerve injury,41596,41608,Nerve injury
+2630978.nxml,C0161479,Nerve injury,41596,41608,Nerve injury
-2630986.nxml,17450006,myoclonus,17004,17013,Myoclonus
+2630986.nxml,C0027066,myoclonus,17004,17013,Myoclonus
-2630986.nxml,410429000,cardiac arrest,20952,20966,Cardiac arrest 
+2630986.nxml,C0018790,cardiac arrest,20952,20966,Cardiac arrest 
-2630993.nxml,7793005,problems of the lower urinary tract,2962,2997,Disorder of the lower urinary tract
+2630993.nxml,C0268818,problems of the lower urinary tract,2962,2997,Disorder of the lower urinary tract
-2631025.nxml,84478008,occupational therapy,22527,22547,Occupational therapy
+2631025.nxml,C1318464,occupational therapy,22527,22547,Occupational therapy
-2631157.nxml,223357005,Armed Forces,625,637,Armed forces
+2631157.nxml,C0402580,Armed Forces,625,637,Armed forces
-2631192.nxml,44376007,hysteria,36944,36952,Hysteria
+2631192.nxml,C0020701,hysteria,36944,36952,Hysteria
-2631457.nxml,76976005,Optic atrophy,11537,11550,Optic atrophy
+2631457.nxml,C0029124,Optic atrophy,11537,11550,Optic atrophy
-2631490.nxml,43064006,Hydronephrosis,7055,7069,Hydronephrosis
+2631490.nxml,C0020295,Hydronephrosis,7055,7069,Hydronephrosis
-2631497.nxml,281255004,small bowel obstruction,13919,13942,Small bowel obstruction
+2631497.nxml,C0235329,small bowel obstruction,13919,13942,Small bowel obstruction
-2631515.nxml,181817002,vertebra c7,27835,27846,C7 vertebra
+2631515.nxml,C1306475,vertebra c7,27835,27846,C7 vertebra
-2631525.nxml,386556002,Tympanoplasty,16696,16709,Tympanoplasty
+2631525.nxml,C0041447,Tympanoplasty,16696,16709,Tympanoplasty
-2631537.nxml,82313006,attempted suicide,2931,2948,Suicide attempt
+2631537.nxml,C0038663,attempted suicide,2931,2948,Suicide attempt
-2631537.nxml,17369002,Spontaneous abortion,3676,3696,Spontaneous abortion
+2631537.nxml,C0000786,Spontaneous abortion,3676,3696,Spontaneous abortion
-2631893.nxml,3764006,Trichomonas,1233,1244,Trichomonas
+2631893.nxml,C0040919,Trichomonas,1233,1244,Trichomonas
-2632387.nxml,5294002,Developmental disorder,32020,32042,Developmental disorder
+2632387.nxml,C0008073,Developmental disorder,32020,32042,Developmental disorder
-2632390.nxml,308540004,Inpatient stay,23030,23044,Inpatient stay
+2632390.nxml,C0420512,Inpatient stay,23030,23044,Inpatient stay
-2632733.nxml,84172003,Spondylitis,17014,17025,Spondylitis
+2632733.nxml,C0038012,Spondylitis,17014,17025,Spondylitis
-2632742.nxml,23853001,CNS disorders,25228,25241,Central nervous system (CNS) disease
+2632742.nxml,C0007682,CNS disorders,25228,25241,Central nervous system (CNS) disease
-2633157.nxml,40055000,Chronic sinusitis,5892,5909,Chronic sinusitis
+2633157.nxml,C0149516,Chronic sinusitis,5892,5909,Chronic sinusitis
-2633322.nxml,37373007,Meckel diverticulum,6405,6424,meckel diverticulum
+2633322.nxml,C0025037,Meckel diverticulum,6405,6424,meckel diverticulum
-2633339.nxml,46903006,Hydrotherapy,12979,12991,hydrotherapy
+2633339.nxml,C0020311,Hydrotherapy,12979,12991,hydrotherapy
-2633454.nxml,43075005,Partial colectomy,13206,13223,Partial colectomy
+2633454.nxml,C0149750,Partial colectomy,13206,13223,Partial colectomy
-2633454.nxml,385486001,Postoperative complication,8981,9007,Postoperative complication
+2633454.nxml,C0032787,Postoperative complication,8981,9007,Postoperative complication
-2634611.nxml,19471005,Lymphadenitis,18408,18421,lymphadenitis
+2634611.nxml,C0024205,Lymphadenitis,18408,18421,lymphadenitis
-2634615.nxml,309934006,division of Infectious Diseases,626,657,Infectious diseases department
+2634615.nxml,C0587472,division of Infectious Diseases,626,657,Infectious diseases department
-2634747.nxml,9707006,volvulus,12743,12751,Volvulus
+2634747.nxml,C0042961,volvulus,12743,12751,Volvulus
-2634777.nxml,373756000,ringer solution,6027,6042,Ringer's solution
+2634777.nxml,C0073386,ringer solution,6027,6042,Ringer's solution
-2636021.nxml,399054005,exotropia,2282,2291,Exotropia
+2636021.nxml,C0015310,exotropia,2282,2291,Exotropia
-2636023.nxml,80093006,enophthalmos,5079,5091,Enophthalmos
+2636023.nxml,C0014306,enophthalmos,5079,5091,Enophthalmos
-2636167.nxml,43363007,posterior uveitis,12003,12020,Posterior uveitis
+2636167.nxml,C0042167,posterior uveitis,12003,12020,Posterior uveitis
-2636175.nxml,48677004,scarring,25098,25106,Scarring
+2636175.nxml,C2004491,scarring,25098,25106,Scarring
-2636754.nxml,81680005,neck pain,23435,23444,Neck pain
+2636754.nxml,C0007859,neck pain,23435,23444,Neck pain
-2636778.nxml,74728003,hypopituitarism,10421,10436,Hypopituitarism
+2636778.nxml,C0020635,hypopituitarism,10421,10436,Hypopituitarism
-2637092.nxml,388990007,synovectomy,9711,9722,Synovectomy
+2637092.nxml,C0185304,synovectomy,9711,9722,Synovectomy
-2637256.nxml,398050005,colonic diverticulosis,7679,7701,Diverticular disease of colon
+2637256.nxml,C0012819,colonic diverticulosis,7679,7701,Diverticular disease of colon
-2638468.nxml,372148003,ethnic group,8692,8716,Ethnic group
+2638468.nxml,C0015031,ethnic group,8692,8716,Ethnic group
-2638696.nxml,394591006,neurology,59640,59649,Neurology
+2638696.nxml,C0027855,neurology,59640,59649,Neurology
-2639208.nxml,26929004,Alzheimer's disease,10524,10543,Alzheimer's disease
+2639208.nxml,C0002395,Alzheimer's disease,10524,10543,Alzheimer's disease
-2639314.nxml,386134007,Significant,3402,3413,Significant
+2639314.nxml,C0750502,Significant,3402,3413,Significant
-2640351.nxml,167593009,feces examination,7009,7026,Feces examination - general
+2640351.nxml,C0202010,feces examination,7009,7026,Feces examination - general
-2640351.nxml,167592004,feces examination,7009,7026,examination of feces
+2640351.nxml,C0202010,feces examination,7009,7026,examination of feces
-2642994.nxml,87697008,Punch biopsy of skin,8046,8066,Punch biopsy of skin
+2642994.nxml,C0191321,Punch biopsy of skin,8046,8066,Punch biopsy of skin
-2643098.nxml,23680005,Enthesopathy,3712,3724,Enthesopathy
+2643098.nxml,C0242490,Enthesopathy,3712,3724,Enthesopathy
-2643102.nxml,48440001,Gouty arthritis,39777,39792,Gouty arthritis
+2643102.nxml,C0003868,Gouty arthritis,39777,39792,Gouty arthritis
-2643118.nxml,105593004,Electrolyte imbalance,5272,5293,Electrolyte imbalance
+2643118.nxml,C0342579,Electrolyte imbalance,5272,5293,Electrolyte imbalance
-2643119.nxml,90739004,Thyrotoxicosis,5243,5257,Thyrotoxicosis
+2643119.nxml,C0040156,Thyrotoxicosis,5243,5257,Thyrotoxicosis
-2644596.nxml,68130003,Physical activity,35348,35365,Physical activity
+2644596.nxml,C0026606,Physical activity,35348,35365,Physical activity
-2645396.nxml,255216001,first,39068,39073,First
+2645396.nxml,C0205435,first,39068,39073,First
-2645707.nxml,129574000,Postoperative myocardial infarction,54350,54385,Postoperative myocardial infarction
+2645707.nxml,C0589368,Postoperative myocardial infarction,54350,54385,Postoperative myocardial infarction
-2646129.nxml,71616004,Muscle,5722,5728,Muscle
+2646129.nxml,C1305763,Muscle,5722,5728,Muscle
-2646717.nxml,260222006,single photon emission computed tomography,8820,8863,SPET - Single photon emission computed tomography
+2646717.nxml,C0040399,single photon emission computed tomography,8820,8863,SPET - Single photon emission computed tomography
-2649137.nxml,35489007,Depression,27087,27097,Depression
+2649137.nxml,C1269683,Depression,27087,27097,Depression
-2644630.nxml,225423004,other therapy schemes,19341,19362,Complementary therapy
+2644630.nxml,C0936077,other therapy schemes,19341,19362,Complementary therapy
--- a/Direct Maintenance/DataSet_2016/snomedct_impacted_2016.csv
+++ b/Direct Maintenance/DataSet_2016/snomedct_impacted_2016.csv
-document,concept,annotation,start,end,kosAtt
+document,concept,annotation,start,end
-2630847.nxml,168392001,Microbiology,43328,43340,
+2630847.nxml,C0085672,Microbiology,43328,43340
-2630851.nxml,188743000,myeloid leukemia,27071,27087,
+2630851.nxml,C0023470,myeloid leukemia,27071,27087
-2630920.nxml,185532009,screening method,6574,6590,
+2630920.nxml,C0422392,screening method,6574,6590
-2630928.nxml,394834005,management,34305,34315,
+2630928.nxml,C1273870,management,34305,34315
-2630928.nxml,313267000,stroke,10519,10525,
+2630928.nxml,C0038454,stroke,10519,10525
-2630947.nxml,197403005,cholelithiasis,13526,13540,
+2630947.nxml,C0008350,cholelithiasis,13526,13540
-2630959.nxml,203440004,osteoporosis,14225,14237,
+2630959.nxml,C0029456,osteoporosis,14225,14237
-2630959.nxml,191579000,schizophrenia,4032,4045,
+2630959.nxml,C0036341,schizophrenia,4032,4045
-2630962.nxml,182621009,vibration,4093,4102,
+2630962.nxml,C0455941,vibration,4093,4102
-2630976.nxml,192831003,Parkinson's disease,1308,1327,
+2630976.nxml,C0030567,Parkinson's disease,1308,1327
-2630978.nxml,269403009,nerve injury,41596,41608,
+2630978.nxml,C0161479,nerve injury,41596,41608
-2630986.nxml,267583001,myoclonus,17004,17013,
+2630986.nxml,C0027066,myoclonus,17004,17013
-2630986.nxml,309810002,cardiac arrest,20952,20966,
+2630986.nxml,C0018790,cardiac arrest,20952,20966
-2630993.nxml,181429003,lower urinary tract,2978,2997,
+2630993.nxml,C0447570,lower urinary tract,2978,2997
-2631025.nxml,183346008,occupational therapy,22527,22547,
+2631025.nxml,C1318464,occupational therapy,22527,22547
-2631157.nxml,265983006,Armed Forces,625,637,
+2631157.nxml,C0402580,Armed Forces,625,637
-2631192.nxml,268629005,hysteria,36944,36952,
+2631192.nxml,C0020701,hysteria,36944,36952
-2631457.nxml,194046007,Optic atrophy,11537,11550,
+2631457.nxml,C0029124,Optic atrophy,11537,11550
-2631490.nxml,197791000,hydronephrosis,7055,7069,
+2631490.nxml,C0020295,hydronephrosis,7055,7069
-2631497.nxml,235802005,small bowel obstruction,13919,13942,
+2631497.nxml,C0235329,small bowel obstruction,13919,13942
-2631515.nxml,181852005,vertebra,27835,27843,
+2631515.nxml,C0447984,vertebra,27835,27843
-2631525.nxml,307717004,Tympanoplasty,16696,16709,
+2631525.nxml,C0585590,Tympanoplasty,16696,16709
-2631537.nxml,287187001,attempted suicide,2931,2948,
+2631537.nxml,C0038663,attempted suicide,2931,2948
-2631537.nxml,198689000,spontaneous abortion,3676,3696,
+2631537.nxml,C0000786,spontaneous abortion,3676,3696
-2631893.nxml,187206001,Trichomonas,1233,1244,
+2631893.nxml,C0040921,Trichomonas,1233,1244
-2632387.nxml,192149001,developmental disorder,32020,32042,
+2632387.nxml,C0008073,developmental disorder,32020,32042
-2632390.nxml,183813006,inpatient stay,23030,23044,
+2632390.nxml,C0420512,inpatient stay,23030,23044
-2632733.nxml,202654007,Spondylitis,17014,17025,
+2632733.nxml,C0038012,Spondylitis,17014,17025
-2633157.nxml,195792008,chronic sinusitis,5892,5909,
+2633157.nxml,C0149516,chronic sinusitis,5892,5909
-2633322.nxml,31113003,diverticulum,6412,6424,
+2633322.nxml,C0012817,diverticulum,6412,6424
-2633339.nxml,182626004,Hydrotherapy,12979,12991,
+2633339.nxml,C0020311,Hydrotherapy,12979,12991
-2633454.nxml,174113006,Partial colectomy,13206,13223,
+2633454.nxml,C0400031,Partial colectomy,13206,13223
-2633454.nxml,213302007,postoperative complication,8981,9007,
+2633454.nxml,C0032787,postoperative complication,8981,9007
-2634611.nxml,287688007,lymphadenitis,18408,18421,
+2634611.nxml,C0024205,lymphadenitis,18408,18421
-2634615.nxml,266171003,Infectious Diseases,638,657,
+2634615.nxml,C0009450,Infectious Diseases,638,657
-2634747.nxml,197061002,volvulus,12743,12751,
+2634747.nxml,C0042961,volvulus,12743,12751
-2636021.nxml,194098009,exotropia,2282,2291,
+2636021.nxml,C0015310,exotropia,2282,2291
-2636023.nxml,194031000,enophthalmos,5079,5091,
+2636023.nxml,C0014306,enophthalmos,5079,5091
-2636167.nxml,193451001,posterior uveitis,12003,12020,
+2636167.nxml,C0042167,posterior uveitis,12003,12020
-2636175.nxml,255450007,scarring,25098,25106,
+2636175.nxml,C2004491,scarring,25098,25106
-2636754.nxml,268078004,neck pain,23435,23444,
+2636754.nxml,C0007859,neck pain,23435,23444
-2636778.nxml,237681002,hypopituitarism,10421,10436,
+2636778.nxml,C0020635,hypopituitarism,10421,10436
-2637092.nxml,415695005,synovectomy,9711,9722,
+2637092.nxml,C1532181,synovectomy,9711,9722
-2637256.nxml,197094004,diverticulosis,7687,7701,
+2637256.nxml,C1510475,diverticulosis,7687,7701
-2646641.nxml,275998009,bone,50209,50213,
+2646641.nxml,C0555828,bone,50209,50213
-2646717.nxml,146258003,Tomography,8852,8863,
+2646717.nxml,C0040395,Tomography,8852,8863
-2646717.nxml,146281001,Computed Tomography,8843,8863,
+2646717.nxml,C0040405,Computed Tomography,8843,8863
-2634777.nxml,77899000,solution,6034,6042,
+2634777.nxml,C0525069,solution,6034,6042
-2643102.nxml,201672003,gouty arthritis,39777,39792,
+2643102.nxml,C0003868,gouty arthritis,39777,39792
-2645707.nxml,311797004,postoperative myocardial infarction,54350,54385,
+2645707.nxml,C0589368,postoperative myocardial infarction,54350,54385
-2649137.nxml,41006004,depression,27087,27097,
+2649137.nxml,C0344315,depression,27087,27097
-2643098.nxml,202890003,Enthesopathy,3712,3724,
+2643098.nxml,C0242490,Enthesopathy,3712,3724
-2642994.nxml,177345003,punch biopsy of skin,8046,8066,
+2642994.nxml,C0191321,punch biopsy of skin,8046,8066
-2630849.nxml,212993008,adverse effects,2874,2889,
+2630849.nxml,C0001687,adverse effects,2874,2889
-2632742.nxml,267700003,CNS disorders,25228,25241,
+2632742.nxml,C0007682,CNS disorders,25228,25241
-2638468.nxml,315282008,other ethnic group,8698,8716,
+2638468.nxml,C1278530,other ethnic group,8698,8716
-2638696.nxml,394331008,Neurology,59640,59649,
+2638696.nxml,C0027855,Neurology,59640,59649
-2639208.nxml,73768007,Alzheimer's disease,10524,10543,
+2639208.nxml,C0002395,Alzheimer's disease,10524,10543
-2639314.nxml,394428006,significant,3402,3413,
+2639314.nxml,C0750502,significant,3402,3413
-2640351.nxml,167696007,feces examination,7009,7026,
+2640351.nxml,C0202010,feces examination,7009,7026
-2643118.nxml,190903001,electrolyte imbalance,5272,5293,
+2643118.nxml,C0342579,electrolyte imbalance,5272,5293
-2643119.nxml,190267008,thyrotoxicosis,5243,5257,
+2643119.nxml,C0040156,thyrotoxicosis,5243,5257
-2644596.nxml,390028005,physical activity,35348,35365,
+2644596.nxml,C0026606,physical activity,35348,35365
-2645396.nxml,90215005,First,39068,39073,
+2645396.nxml,C1279901,First,39068,39073
-2646129.nxml,181755001,muscle,5722,5728,
+2646129.nxml,C0448278,muscle,5722,5728
-2644630.nxml,182812006,other therapy,19341,19354,
+2644630.nxml,C0418967,other therapy,19341,19354
--- a/Direct Maintenance/DataSet_2016/snomedct_original_2009.csv
+++ b/Direct Maintenance/DataSet_2016/snomedct_original_2009.csv
-kos;document;concept;sentence;startOffset;endOffset;prefix;sufix
+kos,document,concept,sentence,startOffset,endOffset,prefix,sufix
-SNOMED2009;2630847.nxml;168392001;Microbiology;43328;43340; applied and environmental; 2004 70 7520 7529 15574955
+SNOMED2009,2630847.nxml,C0085672,Microbiology,43328,43340, applied and environmental, 2004 70 7520 7529 15574955
-SNOMED2009;2630849.nxml;212993008;adverse effects;2874;2889; and humans at risk for; during and subsequent to
+SNOMED2009,2630849.nxml,C0001687,adverse effects,2874,2889, and humans at risk for, during and subsequent to
-SNOMED2009;2630851.nxml;188732008;myeloid leukemia;27071;27087; clavularia viridis on human; (hl-60) cells biochem. biophys.
+SNOMED2009,2630851.nxml,C0023470,myeloid leukemia,27071,27087, clavularia viridis on human, (hl-60) cells biochem. biophys.
-SNOMED2009;2630920.nxml;185532009;screening method;6574;6590; cost-effective multiplex genetic; in order to determine
+SNOMED2009,2630920.nxml,C0422392,screening method,6574,6590, cost-effective multiplex genetic, in order to determine
-SNOMED2009;2630927.nxml;256640005;ptfe;12633;12637; ring-reinforced ; to prevent compression
+SNOMED2009,2630927.nxml,C0032611,ptfe,12633,12637, ring-reinforced , to prevent compression
-SNOMED2009;2630928.nxml;313267000;stroke;10519;10525; and 1.0% reported having a; in kp vs. 0.2% in
+SNOMED2009,2630928.nxml,C0038454,stroke,10519,10525, and 1.0% reported having a, in kp vs. 0.2% in
-SNOMED2009;2630947.nxml;197403005;cholelithiasis;13526;13540; illnesses (such as cholecystitis,;, polyp formation, obstruction
+SNOMED2009,2630947.nxml,C0008350,cholelithiasis,13526,13540," illnesses (such as cholecystitis,",", polyp formation, obstruction"
-SNOMED2009;2630959.nxml;203440004;osteoporosis;14225;14237; bronchitis/emphysema, diabetes,;, fibromyalgia/chronic pain
+SNOMED2009,2630959.nxml,C0029456,osteoporosis,14225,14237," bronchitis/emphysema, diabetes,",", fibromyalgia/chronic pain"
-SNOMED2009;2630959.nxml;191579000;schizophrenia;4032;4045; be most relevant for;, the social causation
+SNOMED2009,2630959.nxml,C0036341,schizophrenia,4032,4045, be most relevant for,", the social causation"
-SNOMED2009;2630962.nxml;182621009;vibration;4093;4102; bending and twisting, whole-body;, manual materials
+SNOMED2009,2630962.nxml,C0455941,vibration,4093,4102," bending and twisting, whole-body",", manual materials"
-SNOMED2009;2630976.nxml;192831003;Parkinson's disease;1308;1327; freezing in people with;. the primary aim
+SNOMED2009,2630976.nxml,C0030567,Parkinson's disease,1308,1327, freezing in people with,. the primary aim
-SNOMED2009;2630978.nxml;269403009;nerve injury;41596;41608; after inferior alveolar; neurosci lett 1998 254 37
+SNOMED2009,2630978.nxml,C0161479,nerve injury,41596,41608, after inferior alveolar, neurosci lett 1998 254 37
-SNOMED2009;2630986.nxml;267583001;myoclonus;17004;17013; predictors at day 1:;, extensor or absent motor 
+SNOMED2009,2630986.nxml,C0027066,myoclonus,17004,17013, predictors at day 1:,", extensor or absent motor "
-SNOMED2009;2630986.nxml;309810002;cardiac arrest;20952;20966; unconscious 24 hours after; [ 2 , 3 , 5 , 8 ,
+SNOMED2009,2630986.nxml,C0018790,cardiac arrest,20952,20966, unconscious 24 hours after," [ 2 , 3 , 5 , 8 ,"
-SNOMED2009;2630993.nxml;181429003;lower urinary tract;2978;2997; such problems of the;. case presentation a 62-year
+SNOMED2009,2630993.nxml,C0447570,lower urinary tract,2978,2997, such problems of the,. case presentation a 62-year
-SNOMED2009;2631025.nxml;183346008;occupational therapy;22527;22547; as a component of; am j occup ther 1991
+SNOMED2009,2631025.nxml,C1318464,occupational therapy,22527,22547, as a component of, am j occup ther 1991
-SNOMED2009;2631157.nxml;265983006;Armed Forces;625;637; and breast pathology,; institute of pathology and
+SNOMED2009,2631157.nxml,C0402580,Armed Forces,625,637," and breast pathology,", institute of pathology and
-SNOMED2009;2631192.nxml;268629005;hysteria;36944;36952; for somatization disorder ;) am j psychiatry 142
+SNOMED2009,2631192.nxml,C0020701,hysteria,36944,36952, for somatization disorder ,) am j psychiatry 142
-SNOMED2009;2631457.nxml;194046007;Optic atrophy;11537;11550; 5 macular hole 2; 4 total 217 visual acuity (aided)
+SNOMED2009,2631457.nxml,C0029124,Optic atrophy,11537,11550, 5 macular hole 2, 4 total 217 visual acuity (aided)
-SNOMED2009;2631458.nxml;224871002;University;939;949; and biophysics, second; of naples, italy 2009 13 1 2009
+SNOMED2009,2631458.nxml,C0041740,University,939,949," and biophysics, second"," of naples, italy 2009 13 1 2009"
-SNOMED2009;2631490.nxml;197791000;hydronephrosis;7055;7069; the presence of;. after that, the
+SNOMED2009,2631490.nxml,C0020295,hydronephrosis,7055,7069, the presence of,". after that, the"
-SNOMED2009;2631497.nxml;235802005;small bowel obstruction;13919;13942; operation for adhesive; ann surg 2004 240
+SNOMED2009,2631497.nxml,C0235329,small bowel obstruction,13919,13942, operation for adhesive, ann surg 2004 240
-SNOMED2009;2631515.nxml;181852005;vertebra;27835;27843; interscapular region dorsal to; c7. recording during recording, the
+SNOMED2009,2631515.nxml,C0447984,vertebra,27835,27843, interscapular region dorsal to," c7. recording during recording, the"
-SNOMED2009;2631525.nxml;307717004;Tympanoplasty;16696;16709; dp garcia e;: surgical results and
+SNOMED2009,2631525.nxml,C0585590,Tympanoplasty,16696,16709, dp garcia e,: surgical results and
-SNOMED2009;2631537.nxml;287187001;attempted suicide;2931;2948; psychiatry department for; by medicinal overdose. the
+SNOMED2009,2631537.nxml,C0038663,attempted suicide,2931,2948, psychiatry department for, by medicinal overdose. the
-SNOMED2009;2631537.nxml;198689000;spontaneous abortion;3676;3696; and had suffered a; in the 3rd month
+SNOMED2009,2631537.nxml,C0000786,spontaneous abortion,3676,3696, and had suffered a, in the 3rd month
-SNOMED2009;2631893.nxml;187206001;Trichomonas;1233;1244; amplifying effect since; is so common. substantial
+SNOMED2009,2631893.nxml,C0040921,Trichomonas,1233,1244, amplifying effect since, is so common. substantial
-SNOMED2009;2632387.nxml;192149001;developmental disorder;32020;32042; “childhood schizophrenia” as a; j am acad child adolesc
+SNOMED2009,2632387.nxml,C0008073,developmental disorder,32020,32042, “childhood schizophrenia” as a, j am acad child adolesc
-SNOMED2009;2632390.nxml;183813006;inpatient stay;23030;23044; days with length of; as the dependent variable.
+SNOMED2009,2632390.nxml,C0420512,inpatient stay,23030,23044, days with length of, as the dependent variable.
-SNOMED2009;2632733.nxml;202654007;Spondylitis;17014;17025; physicians, and the; association of america for
+SNOMED2009,2632733.nxml,C0038012,Spondylitis,17014,17025," physicians, and the", association of america for
-SNOMED2009;2632742.nxml;266993007;CNS disorders;25228;25241; phones and risk of;. most of the
+SNOMED2009,2632742.nxml,C0007682,CNS disorders,25228,25241, phones and risk of,. most of the
-SNOMED2009;2632913.nxml;267716001;myenteric plexus;24647;24663; hoover ea prpcwd in the;, vagosympathetic trunk and
+SNOMED2009,2632913.nxml,C1280770,myenteric plexus,24647,24663, hoover ea prpcwd in the,", vagosympathetic trunk and"
-SNOMED2009;2633157.nxml;195792008;chronic sinusitis;5892;5909; in the patients with;, altering the vulnerable
+SNOMED2009,2633157.nxml,C0149516,chronic sinusitis,5892,5909, in the patients with,", altering the vulnerable"
-SNOMED2009;2633286.nxml;61774002;rotator cuff repair;34480;34499; scores in persons after; surgery: impairment measures are
+SNOMED2009,2633286.nxml,C0186666,rotator cuff repair,34480,34499, scores in persons after, surgery: impairment measures are
-SNOMED2009;2633322.nxml;31113003;diverticulum;6412;6424; association with the meckel;, the appendix,
+SNOMED2009,2633322.nxml,C0012817,diverticulum,6412,6424, association with the meckel,", the appendix,"
-SNOMED2009;2633339.nxml;182626004;Hydrotherapy;12979;12991; transfers and mobility.; was introduced as soon as
+SNOMED2009,2633339.nxml,C0020311,Hydrotherapy,12979,12991, transfers and mobility., was introduced as soon as
-SNOMED2009;2633454.nxml;174113006;Partial colectomy;13206;13223; 4 ] 1980 23 crohn's; no no no no
+SNOMED2009,2633454.nxml,C0400031,Partial colectomy,13206,13223, 4 ] 1980 23 crohn's, no no no no
-SNOMED2009;2633454.nxml;213302007;postoperative complication;8981;9007; enteritis: an early; in inflammatory bowel disease
+SNOMED2009,2633454.nxml,C0032787,postoperative complication,8981,9007, enteritis: an early, in inflammatory bowel disease
-SNOMED2009;2634611.nxml;287688007;lymphadenitis;18408;18421; 55 ?m. figure 4 focal histiocytic; caused by mycobacterium bovis in
+SNOMED2009,2634611.nxml,C0024205,lymphadenitis,18408,18421, 55 ?m. figure 4 focal histiocytic, caused by mycobacterium bovis in
-SNOMED2009;2634615.nxml;309934005;Infectious Diseases;638;657; westling, division of;, department of
+SNOMED2009,2634615.nxml,C0009450,Infectious Diseases,638,657," westling, division of",", department of"
-SNOMED2009;2634747.nxml;197061002;volvulus;12743;12751; intron 2 of the o.; cpz gene sequence
+SNOMED2009,2634747.nxml,C0042961,volvulus,12743,12751, intron 2 of the o., cpz gene sequence
-SNOMED2009;2634776.nxml;255586005;mean;12365;12369; groups (p<.05). the lowest; debris weight was related to
+SNOMED2009,2634776.nxml,C0444504,mean,12365,12369, groups (p<.05). the lowest, debris weight was related to
-SNOMED2009;2634777.nxml;77899000;solution;6034;6042; of sodium azide in ringer; until the date of use
+SNOMED2009,2634777.nxml,C0525069,solution,6034,6042, of sodium azide in ringer, until the date of use
-SNOMED2009;2635572.nxml;246261001;group;59892;59897; mite hosts. thus the; is interesting from an
+SNOMED2009,2635572.nxml,C0441833,group,59892,59897, mite hosts. thus the, is interesting from an
-SNOMED2009;2636021.nxml;194098009;exotropia;2282;2291; years of age because of; (xt) l/e that reportedly
+SNOMED2009,2636021.nxml,C0015310,exotropia,2282,2291, years of age because of, (xt) l/e that reportedly
-SNOMED2009;2636023.nxml;194031000;enophthalmos;5079;5091; with miosis, apparent; of right eye and anhidrosis
+SNOMED2009,2636023.nxml,C0014306,enophthalmos,5079,5091," with miosis, apparent", of right eye and anhidrosis
-SNOMED2009;2636167.nxml;193451001;posterior uveitis;12003;12020; scales of vr-qol. patients with; showed more improvementthan either
+SNOMED2009,2636167.nxml,C0042167,posterior uveitis,12003,12020, scales of vr-qol. patients with, showed more improvementthan either
-SNOMED2009;2636175.nxml;48677004;scarring;25098;25106; central cornea with minimal; (yellow arrow) and residual
+SNOMED2009,2636175.nxml,C2004491,scarring,25098,25106, central cornea with minimal, (yellow arrow) and residual
-SNOMED2009;2636754.nxml;81680005;neck pain;23435;23444; risk factors for; in the general population
+SNOMED2009,2636754.nxml,C0007859,neck pain,23435,23444, risk factors for, in the general population
-SNOMED2009;2636778.nxml;237681002;hypopituitarism;10421;10436; diabetes, arthropathy,;, skin pigmentation
+SNOMED2009,2636778.nxml,C0020635,hypopituitarism,10421,10436," diabetes, arthropathy,",", skin pigmentation"
-SNOMED2009;2637092.nxml;415695005;synovectomy;9711;9722; experience pain during;, so extensive synovitis
+SNOMED2009,2637092.nxml,C1532181,synovectomy,9711,9722, experience pain during,", so extensive synovitis"
-SNOMED2009;2637256.nxml;197094004;diverticulosis;7687;7701; associated ascending colonic; and no evidence of
+SNOMED2009,2637256.nxml,C1510475,diverticulosis,7687,7701, associated ascending colonic, and no evidence of
-SNOMED2009;2637578.nxml;258099003;fluorescence;25675;25687; was no difference in jc-1; between control and hfd
+SNOMED2009,2637578.nxml,C0016315,fluorescence,25675,25687, was no difference in jc-1, between control and hfd
-SNOMED2009;2637875.nxml;73595000;Stress;59136;59142; activator of stre ; response element)-regulated genes j
+SNOMED2009,2637875.nxml,C0038435,Stress,59136,59142, activator of stre , response element)-regulated genes j
-SNOMED2009;2637924.nxml;260548002;oral;52868;52872; dentition of zebrafish, across; and pharyngeal dentitions in
+SNOMED2009,2637924.nxml,C0442027,oral,52868,52872," dentition of zebrafish, across", and pharyngeal dentitions in
-SNOMED2009;2637981.nxml;278412004;human;42394;42399; detection using rabbit anti; ccr5 monoclonal antibody (
+SNOMED2009,2637981.nxml,C0086418,human,42394,42399, detection using rabbit anti, ccr5 monoclonal antibody (
-SNOMED2009;2638468.nxml;315282008;other ethnic group;8698;8716; and was included in the; category. hpv testing standardized
+SNOMED2009,2638468.nxml,C1278530,other ethnic group,8698,8716, and was included in the, category. hpv testing standardized
-SNOMED2009;2638696.nxml;394591006;Neurology;59640;59649; the world federation of; committee on research (miller et
+SNOMED2009,2638696.nxml,C0027855,Neurology,59640,59649, the world federation of, committee on research (miller et
-SNOMED2009;2639208.nxml;26929004;Alzheimer's disease;10524;10543; the criteria for probable; ( n = 33), or were
+SNOMED2009,2639208.nxml,C0002395,Alzheimer's disease,10524,10543, the criteria for probable," ( n = 33), or were"
-SNOMED2009;2639314.nxml;386134007;significant;3402;3413; of boec resulted in a; decrease in both hif-1?
+SNOMED2009,2639314.nxml,C0750502,significant,3402,3413, of boec resulted in a, decrease in both hif-1?
-SNOMED2009;2639700.nxml;256235009;exercise;3492;3500; 4 and 8 kkw of; (72 and 136 minutes respectively),
+SNOMED2009,2639700.nxml,C0015259,exercise,3492,3500, 4 and 8 kkw of," (72 and 136 minutes respectively),"
-SNOMED2009;2640351.nxml;167696007;feces examination;7009;7026; chemical and microscopic; showed leukocytes 2–3
+SNOMED2009,2640351.nxml,C0202010,feces examination,7009,7026, chemical and microscopic, showed leukocytes 2–3
-SNOMED2009;2642725.nxml;41146007;bacteria;43028;43036; host cells through the;#NAME?
+SNOMED2009,2642725.nxml,C0004611,bacteria,43028,43036, host cells through the,#NAME?
-SNOMED2009;2642825.nxml;76670001;Duchenne muscular dystrophy;71118;71145; intermittent prednisone therapy in;: a randomized controlled
+SNOMED2009,2642825.nxml,C0013264,Duchenne muscular dystrophy,71118,71145, intermittent prednisone therapy in,: a randomized controlled
-SNOMED2009;2642994.nxml;177345003;punch biopsy of skin;8046;8066; tumor cells, and a 6-mm; was obtained for analysis
+SNOMED2009,2642994.nxml,C0191321,punch biopsy of skin,8046,8066," tumor cells, and a 6-mm", was obtained for analysis
-SNOMED2009;2643036.nxml;21139007;Organization;9562;9574; later of the world health; and of sightsavers
+SNOMED2009,2643036.nxml,C0029237,Organization,9562,9574, later of the world health, and of sightsavers
-SNOMED2009;2643049.nxml;410681005;number;15453;15459; the specific copy; change were analysed ( fig
+SNOMED2009,2643049.nxml,C0449788,number,15453,15459, the specific copy, change were analysed ( fig
-SNOMED2009;2643098.nxml;202890003;Enthesopathy;3712;3724; ;
+SNOMED2009,2643098.nxml,C0242490,Enthesopathy,3712,3724, ,
-SNOMED2009;2643102.nxml;201672003;gouty arthritis;39777;39792; presence of tophus and/or;), which is the
+SNOMED2009,2643102.nxml,C0003868,gouty arthritis,39777,39792, presence of tophus and/or,"), which is the"
-SNOMED2009;2643118.nxml;190903001;electrolyte imbalance;5272;5293; failure, nephritic syndrome,;, and osteonecrosis of
+SNOMED2009,2643118.nxml,C0342579,electrolyte imbalance,5272,5293," failure, nephritic syndrome,",", and osteonecrosis of"
-SNOMED2009;2643119.nxml;190267008;thyrotoxicosis;5243;5257; of patient one for severe;. she had a history
+SNOMED2009,2643119.nxml,C0040156,thyrotoxicosis,5243,5257, of patient one for severe,. she had a history
-SNOMED2009;2644580.nxml;255470001;local;24664;24669; of cancer at the; level. the area surrounding
+SNOMED2009,2644580.nxml,C0205276,local,24664,24669, of cancer at the, level. the area surrounding
-SNOMED2009;2644596.nxml;68130003;physical activity;35348;35365; n, stewart al. improving; resource guides to bridge
+SNOMED2009,2644596.nxml,C0026606,physical activity,35348,35365," n, stewart al. improving", resource guides to bridge
-SNOMED2009;2644630.nxml;182812006;other therapy;19341;19354; mmf co-medication. all; schemes were only associated
+SNOMED2009,2644630.nxml,C0418967,other therapy,19341,19354, mmf co-medication. all, schemes were only associated
-SNOMED2009;2645396.nxml;255216001;First;39068;39073; can explain this observation.;, the length distribution
+SNOMED2009,2645396.nxml,C0205435,First,39068,39073, can explain this observation.,", the length distribution"
-SNOMED2009;2645707.nxml;311797004;postoperative myocardial infarction;54350;54385; reduction in; with the use of
+SNOMED2009,2645707.nxml,C0589368,postoperative myocardial infarction,54350,54385, reduction in, with the use of
-SNOMED2009;2646066.nxml;412307009;vehicle;37423;37430; p < 0.001 between; and treated groups and
+SNOMED2009,2646066.nxml,C0042444,vehicle,37423,37430, p < 0.001 between, and treated groups and
-SNOMED2009;2646129.nxml;181755001;muscle;5722;5728; with prt on; energetics (e.g. mitochondrial
+SNOMED2009,2646129.nxml,C0448278,muscle,5722,5728, with prt on, energetics (e.g. mitochondrial
-SNOMED2009;2646272.nxml;346649002;provide;12330;12337; in adult-stage tissues might; a window into early
+SNOMED2009,2646272.nxml,C0359589,provide,12330,12337, in adult-stage tissues might, a window into early
-SNOMED2009;2646342.nxml;385425000;improved;3416;3424; not completely account for the; mortality observed in closed
+SNOMED2009,2646342.nxml,C0184511,improved,3416,3424, not completely account for the, mortality observed in closed
-SNOMED2009;2646352.nxml;371930009;possible;28910;28918; therapy as early as; after the diagnosis of
+SNOMED2009,2646352.nxml,C0332149,possible,28910,28918, therapy as early as, after the diagnosis of
-SNOMED2009;2646676.nxml;261600003;group P;17001;17008; (å) 19?1.4 50?1.30 space; 2 1 2 1 2 1 p 2 1
+SNOMED2009,2646676.nxml,C0441849,group P,17001,17008, (å) 19?1.4 50?1.30 space, 2 1 2 1 2 1 p 2 1
-SNOMED2009;2646696.nxml;47429007;associated with;9462;9477; also shown to be; plant pathogen interactions as well
+SNOMED2009,2646696.nxml,C0332281,associated with,9462,9477, also shown to be, plant pathogen interactions as well
-SNOMED2009;2646717.nxml;169040009;Tomography;8852;8863; single photon emission computed; imaging with technetium 99
+SNOMED2009,2646717.nxml,C0040395,Tomography,8852,8863, single photon emission computed, imaging with technetium 99
-SNOMED2009;2647534.nxml;4421005;cell;7895;7899; the s-type; lines. amongst the
+SNOMED2009,2647534.nxml,C0007634,cell,7895,7899, the s-type, lines. amongst the
-SNOMED2009;2647963.nxml;246062003;origin;5068;5074; the case reported here. the; of the aot is controversial. 12
+SNOMED2009,2647963.nxml,C0439659,origin,5068,5074, the case reported here. the, of the aot is controversial. 12
-SNOMED2009;2648659.nxml;223686002;Canada;62082;62088; and transmission in;. driving factors potential
+SNOMED2009,2648659.nxml,C0006823,Canada,62082,62088, and transmission in,. driving factors potential
-SNOMED2009;2649019.nxml;410670007;Time;65629;65633; abi 7900 real; fluorescence detection system (abi)
+SNOMED2009,2649019.nxml,C0040223,Time,65629,65633, abi 7900 real, fluorescence detection system (abi)
-SNOMED2009;2649036.nxml;14468000;Sports;36978;36984; training j int soc; nutr 2006 3 s9 stout jr
+SNOMED2009,2649036.nxml,C0038039,Sports,36978,36984, training j int soc, nutr 2006 3 s9 stout jr
-SNOMED2009;2649042.nxml;35105006;increased;6644;6653; such as testing if; expression of erbb2 promoter
+SNOMED2009,2649042.nxml,C0205217,increased,6644,6653, such as testing if, expression of erbb2 promoter
-SNOMED2009;2649137.nxml;41006004;depression;27087;27097; can also speculate that inbreeding; consequent to isolation and
+SNOMED2009,2649137.nxml,C0344315,depression,27087,27097, can also speculate that inbreeding, consequent to isolation and
\ No newline at end of file